BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fulda S. Tumor resistance to apoptosis. Int J Cancer. 2009;124:511-515. [PMID: 19003982 DOI: 10.1002/ijc.24064] [Cited by in Crossref: 390] [Cited by in F6Publishing: 410] [Article Influence: 26.0] [Reference Citation Analysis]
Number Citing Articles
1 Hatami M, Kouchak M, Khorsandi L, Rashidi M, Alireza Kheirollah2. Quercetin-loaded Solid Lipid Nanoparticles Effectively Inhibit the Growth of Invasive Breast Cancer Cell Line MDA-MB 231.. [DOI: 10.21203/rs.3.rs-2635092/v1] [Reference Citation Analysis]
2 Ji X, Chu G, Chen Y, Jiao J, Lv T, Yao Q. Comprehensive analysis of novel prognosis-related proteomic signature effectively improve risk stratification and precision treatment for patients with cervical cancer. Arch Gynecol Obstet 2023;307:903-17. [PMID: 35713693 DOI: 10.1007/s00404-022-06642-w] [Reference Citation Analysis]
3 Zheng D, Li J, Yan H, Zhang G, Li W, Chu E, Wei N. Emerging roles of Aurora-A kinase in cancer therapy resistance. Acta Pharmaceutica Sinica B 2023. [DOI: 10.1016/j.apsb.2023.03.013] [Reference Citation Analysis]
4 Almansour NM, Allemailem KS, Abd El Aty AA, Boussoufa D, Ismail Fagiree E, Ibrahim MAA. Venetoclax analogs as promising anticancer therapeutics via targeting Bcl-2 protein: in-silico drug discovery study. J Biomol Struct Dyn 2023;:1-17. [PMID: 36815250 DOI: 10.1080/07391102.2023.2180668] [Reference Citation Analysis]
5 Clorennec CL, Subramonian D, Huo Y, Zage P. UBE4B interacts with the ITCH E3 ubiquitin ligase to induce Ku70 and c-FLIPL polyubiquitination and enhanced neuroblastoma apoptosis.. [DOI: 10.21203/rs.3.rs-2528139/v1] [Reference Citation Analysis]
6 Nössing C, Ryan KM. 50 years on and still very much alive: 'Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics'. Br J Cancer 2023;128:426-31. [PMID: 36369364 DOI: 10.1038/s41416-022-02020-0] [Reference Citation Analysis]
7 Najafi V, Yoosefian M, Hassani Z. Development of venetoclax performance using its new derivatives on BCL-2 protein inhibition. Cell Biochem Funct 2023;41:58-66. [PMID: 36259104 DOI: 10.1002/cbf.3760] [Reference Citation Analysis]
8 Bahreini F, Rezaei N. The Role of MicroRNAs in Chemoresistance. Handbook of Cancer and Immunology 2023. [DOI: 10.1007/978-3-030-80962-1_336-1] [Reference Citation Analysis]
9 Elleithi YA, El-Gayar AM, Amin MN. Simvastatin Induces Apoptosis And Suppresses Hepatocellular Carcinoma Induced In Rats. Appl Biochem Biotechnol 2023;195:1656-74. [PMID: 36367620 DOI: 10.1007/s12010-022-04203-0] [Reference Citation Analysis]
10 Samarth N, Gulhane P, Singh S. Immunoregulatory framework and the role of miRNA in the pathogenesis of NSCLC - A systematic review. Front Oncol 2022;12:1089320. [PMID: 36620544 DOI: 10.3389/fonc.2022.1089320] [Reference Citation Analysis]
11 Saber A, Abedimanesh N, Somi M, Khosroushahi AY, Moradi S. Anticancer properties of red beetroot hydro-alcoholic extract and its main constituent; Betanin on colorectal cancer cell lines.. [DOI: 10.21203/rs.3.rs-2355263/v1] [Reference Citation Analysis]
12 Bui BP, Nguyen PL, Lee K, Cho J. Hypoxia-Inducible Factor-1: A Novel Therapeutic Target for the Management of Cancer, Drug Resistance, and Cancer-Related Pain. Cancers (Basel) 2022;14. [PMID: 36551540 DOI: 10.3390/cancers14246054] [Reference Citation Analysis]
13 Minabian S, Soleimani S S, Torabi M, Mohammadi M, Ranjbar H. Evaluation of P53 protein expression in gingival tissues of patients with chronic periodontitis by immunohistochemistry methods. Clin Exp Dent Res 2022;8:1348-53. [PMID: 36263737 DOI: 10.1002/cre2.668] [Reference Citation Analysis]
14 Chang JS, Chen C, Tikhomirov AS, Islam A, Liang R, Weng C, Wu W, Shchekotikhin AE, Chueh PJ. Bis(chloroacetamidino)-Derived Heteroarene-Fused Anthraquinones Bind to and Cause Proteasomal Degradation of tNOX, Leading to c-Flip Downregulation and Apoptosis in Oral Cancer Cells. Cancers 2022;14:4719. [DOI: 10.3390/cancers14194719] [Reference Citation Analysis]
15 Antonio LC, Ribovski L, Pincela Lins PM, Zucolotto V. The amount of dextran in PLGA nanocarriers modulates protein corona and promotes cell membrane damage. J Mater Chem B 2022. [PMID: 36155711 DOI: 10.1039/d2tb01296k] [Reference Citation Analysis]
16 Sriratanasak N, Wattanathana W, Chanvorachote P. 6,6′-((Methylazanedyl)bis(methylene))bis(2,4-dimethylphenol) Induces Autophagic Associated Cell Death through mTOR-Mediated Autophagy in Lung Cancer. Molecules 2022;27:6230. [DOI: 10.3390/molecules27196230] [Reference Citation Analysis]
17 Brown G. Lessons to cancer from studies of leukemia and hematopoiesis. Front Cell Dev Biol 2022;10:993915. [DOI: 10.3389/fcell.2022.993915] [Reference Citation Analysis]
18 Li Y, Zeng Q, Wang R, Wang B, Chen R, Wang N, Lu Y, Shi F, Dehaen W, Huai Q. Synthesis and discovery of mitochondria-targeting oleanolic acid derivatives for potential PI3K inhibition. Fitoterapia 2022;162:105291. [PMID: 36064154 DOI: 10.1016/j.fitote.2022.105291] [Reference Citation Analysis]
19 Krishna S, Krishna Murthy T, Divyashri G, Murahari M, Shukla R, Birendra Kumar S, Raj Singh T. Pharmacoinformatics based screening of combined synthetic and natural compounds to identify novel and in silico potential Bcl-2 inhibitors. Journal of Molecular Liquids 2022. [DOI: 10.1016/j.molliq.2022.120250] [Reference Citation Analysis]
20 Beteta-göbel R, Miralles M, Fernández-díaz J, Rodríguez-lorca R, Torres M, Fernández-garcía P, Escribá PV, Lladó V. HCA (2-Hydroxy-Docosahexaenoic Acid) Induces Apoptosis and Endoplasmic Reticulum Stress in Pancreatic Cancer Cells. IJMS 2022;23:9902. [DOI: 10.3390/ijms23179902] [Reference Citation Analysis]
21 Xu W, Lai Y, Pan Y, Tan M, Ma Y, Sheng H, Wang J. m6A RNA methylation-mediated NDUFA4 promotes cell proliferation and metabolism in gastric cancer. Cell Death Dis 2022;13:715. [PMID: 35977935 DOI: 10.1038/s41419-022-05132-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Liu J, Hong S, Yang J, Zhang X, Wang Y, Wang H, Peng J, Hong L. Targeting purine metabolism in ovarian cancer. J Ovarian Res 2022;15:93. [PMID: 35964092 DOI: 10.1186/s13048-022-01022-z] [Reference Citation Analysis]
23 Lin H, Wang Y, Wang P, Long F, Wang T. Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance. Mol Cancer 2022;21:148. [PMID: 35843942 DOI: 10.1186/s12943-022-01620-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
24 Gill MR, Jarman PJ, Hearnden V, Fairbanks SD, Bassetto M, Maib H, Palmer J, Ayscough KR, Thomas JA, Smythe C. A Ruthenium(II) Polypyridyl Complex Disrupts Actin Cytoskeleton Assembly and Blocks Cytokinesis. Angew Chem Int Ed 2022;61. [DOI: 10.1002/anie.202117449] [Reference Citation Analysis]
25 Debnath S, Sarkar A, Mukherjee DD, Ray S, Mahata B, Mahata T, Parida PK, Das T, Mukhopadhyay R, Ghosh Z, Biswas K. Eriodictyol mediated selective targeting of the TNFR1/FADD/TRADD axis in cancer cells induce apoptosis and inhibit tumor progression and metastasis. Translational Oncology 2022;21:101433. [DOI: 10.1016/j.tranon.2022.101433] [Reference Citation Analysis]
26 Dogan E, Kara HG, Kosova B, Cetintas VB. Targeting Apoptosis to Overcome Chemotherapy Resistance. Metastasis 2022. [DOI: 10.36255/exon-publications.metastasis.chemotherapy-resistance] [Reference Citation Analysis]
27 Ren X, Cui H, Wu J, Zhou R, Wang N, Liu D, Xie X, Zhang H, Liu D, Ma X, Dang C, Kang H, Lin S. Identification of a combined apoptosis and hypoxia gene signature for predicting prognosis and immune infiltration in breast cancer. Cancer Med 2022. [PMID: 35441810 DOI: 10.1002/cam4.4755] [Reference Citation Analysis]
28 Kalkan H. The Program Cell Death (Apoptosis) and the Therapy of Cancer. Regulation and Dysfunction of Apoptosis 2022. [DOI: 10.5772/intechopen.97289] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Chen C, Wang Z, Jia S, Zhang Y, Ji S, Zhao Z, Kwok RTK, Lam JWY, Ding D, Shi Y, Tang BZ. Evoking Highly Immunogenic Ferroptosis Aided by Intramolecular Motion-Induced Photo-Hyperthermia for Cancer Therapy. Adv Sci (Weinh) 2022;9:e2104885. [PMID: 35132824 DOI: 10.1002/advs.202104885] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
30 Das A, Greco G, Kumar S, Catanzaro E, Morigi R, Locatelli A, Schols D, Alici H, Tahtaci H, Ravindran F, Fimognari C, Karki SS. Synthesis, in vitro cytotoxicity, molecular docking and ADME study of some indolin-2-one linked 1,2,3-triazole derivatives. Computational Biology and Chemistry 2022;97:107641. [DOI: 10.1016/j.compbiolchem.2022.107641] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Bourhis J, Burtness B, Licitra LF, Nutting C, Schoenfeld JD, Omar M, Bouisset F, Nauwelaerts H, Urfer Y, Zanna C, Cohen EE. Xevinapant or placebo plus chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck: TrilynX phase III study design. Future Oncol 2022. [PMID: 35172587 DOI: 10.2217/fon-2021-1634] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Sahyon HAE, Ramadan ENM, Althobaiti F, Mashaly MMA. Anti-proliferative effects of the combination of Sulfamethoxazole and Quercetin via caspase3 and NFkB gene regulation: an in vitro and in vivo study. Naunyn Schmiedebergs Arch Pharmacol 2022;395:227-46. [PMID: 34994822 DOI: 10.1007/s00210-021-02174-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Yu X, Wu T, Liao B, Du Z, Zhu P. Anticancer potential of corilagin on T24 and TSGH 8301 bladder cancer cells via the activation of apoptosis by the suppression of NF-κB-induced P13K/Akt signaling pathway. Environ Toxicol 2022. [PMID: 35084093 DOI: 10.1002/tox.23472] [Reference Citation Analysis]
34 Yasmin T, Kabir Y. Apoptosis in Cancer. Handbook of Cancer and Immunology 2022. [DOI: 10.1007/978-3-030-80962-1_44-1] [Reference Citation Analysis]
35 Cao Y. Possible relationship between the somatic mutations and the formation of cancers. BIO Web Conf 2022;55:01009. [DOI: 10.1051/bioconf/20225501009] [Reference Citation Analysis]
36 Rasheed SAK, Subramanyan LV, Lim WK, Udayappan UK, Wang M, Casey PJ. The emerging roles of Gα12/13 proteins on the hallmarks of cancer in solid tumors. Oncogene 2022;41:147-58. [PMID: 34689178 DOI: 10.1038/s41388-021-02069-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
37 Šimoničová K, Janotka Ľ, Kavcová H, Sulová Z, Breier A, Messingerova L. Different mechanisms of drug resistance to hypomethylating agents in the treatment of myelodysplastic syndromes and acute myeloid leukemia. Drug Resistance Updates 2022. [DOI: 10.1016/j.drup.2022.100805] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
38 Xu X, Yu S, Liu X, Feng Y. Ultrasound-Targeted Microbubble Destruction-Mediated Inhibition of Livin Expression Accelerates Ovarian Cancer Cell Apoptosis. Genet Res (Camb) 2021;2021:7624346. [PMID: 34949962 DOI: 10.1155/2021/7624346] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
39 Shoshan-Barmatz V, Anand U, Nahon-Crystal E, Di Carlo M, Shteinfer-Kuzmine A. Adverse Effects of Metformin From Diabetes to COVID-19, Cancer, Neurodegenerative Diseases, and Aging: Is VDAC1 a Common Target? Front Physiol 2021;12:730048. [PMID: 34671273 DOI: 10.3389/fphys.2021.730048] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
40 Abusalah MAH, Binti Hassan SA, Mat Lazim N, Abdullah B, Binti Wan Sohaimi WF, Husin A, Cheng KY, Yean CY. Design of InnoPrimers-Duplex Real-Time PCR for Detection and Treatment Response Prediction of EBV-Associated Nasopharyngeal Carcinoma Circulating Genetic Biomarker. Diagnostics (Basel) 2021;11:1761. [PMID: 34679459 DOI: 10.3390/diagnostics11101761] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
41 Gong H, Niu Q, Zhou Y, Wang YX, Xu XF, Hou KZ. Notum palmitoleoyl-protein carboxylesterase regulates Fas cell surface death receptor-mediated apoptosis via the Wnt signaling pathway in colon adenocarcinoma. Bioengineered 2021;12:5241-52. [PMID: 34402722 DOI: 10.1080/21655979.2021.1961657] [Reference Citation Analysis]
42 Ni YH, Zhao X, Wang W. CD24, A Review of its Role in Tumor Diagnosis, Progression and Therapy. Curr Gene Ther 2020;20:109-26. [PMID: 32576128 DOI: 10.2174/1566523220666200623170738] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
43 Sharma VK, Singh TG, Singh S, Garg N, Dhiman S. Apoptotic Pathways and Alzheimer's Disease: Probing Therapeutic Potential. Neurochem Res 2021. [PMID: 34386919 DOI: 10.1007/s11064-021-03418-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
44 Wang R, Liu H, Du X, Ma Y, Tian Z, Zhang S, Shi L, Guo H, Zhang H. MicroRNA-122 overexpression promotes apoptosis and tumor suppressor gene expression induced by microcystin-leucine arginine in mouse liver. Int J Environ Health Res 2021;:1-12. [PMID: 34180736 DOI: 10.1080/09603123.2021.1946489] [Reference Citation Analysis]
45 Shuai Z, Zheng Y, Jiang J, Yu R, Zhang C. Design BH3 domain fusion protein as targeting pro-apoptotic self-assembling nanoparticles. Biomed Pharmacother 2021;141:111825. [PMID: 34153848 DOI: 10.1016/j.biopha.2021.111825] [Reference Citation Analysis]
46 Liu X, Sui B, Camargo PH, Wang J, Sun J. Tuning band gap of MnO2 nanoflowers by Alkali metal doping for enhanced Ferroptosis/phototherapy synergism in Cancer. Applied Materials Today 2021;23:101027. [DOI: 10.1016/j.apmt.2021.101027] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
47 Wani SM, Gani A, Mir SA, Masoodi FA, Khanday FA. β-Glucan: A dual regulator of apoptosis and cell proliferation. Int J Biol Macromol 2021;182:1229-37. [PMID: 33991557 DOI: 10.1016/j.ijbiomac.2021.05.065] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
48 Gavamukulya Y, Maina EN, El-Shemy HA, Meroka AM, Kangogo GK, Magoma G, Wamunyokoli F. Annona muricata silver nanoparticles exhibit strong anticancer activities against cervical and prostate adenocarcinomas through regulation of CASP9 and the CXCL1/CXCR2 genes axis. Tumour Biol 2021;43:37-55. [PMID: 33935122 DOI: 10.3233/TUB-200058] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
49 Nengroo MA, Maheshwari S, Singh A, Verma A, Arya RK, Chaturvedi P, Saini KK, Singh AK, Sinha A, Meena S, Gupta A, Mishra A, Sarkar J, Datta D. CXCR4 intracellular protein promotes drug resistance and tumorigenic potential by inversely regulating the expression of Death Receptor 5. Cell Death Dis 2021;12:464. [PMID: 33966046 DOI: 10.1038/s41419-021-03730-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
50 Eissa IH, Dahab MA, Ibrahim MK, Alsaif NA, Alanazi AZ, Eissa SI, Mehany ABM, Beauchemin AM. Design and discovery of new antiproliferative 1,2,4-triazin-3(2H)-ones as tubulin polymerization inhibitors targeting colchicine binding site. Bioorg Chem 2021;112:104965. [PMID: 34020238 DOI: 10.1016/j.bioorg.2021.104965] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 11.0] [Reference Citation Analysis]
51 Krishna S, Kumar SB, Murthy TPK, Murahari M. Structure-based design approach of potential BCL-2 inhibitors for cancer chemotherapy. Comput Biol Med 2021;134:104455. [PMID: 33962088 DOI: 10.1016/j.compbiomed.2021.104455] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
52 Acharya B, Chaijaroenkul W, Na-Bangchang K. Atractylodin inhibited the migration and induced autophagy in cholangiocarcinoma cells via PI3K/AKT/mTOR and p38MAPK signalling pathways. J Pharm Pharmacol 2021:rgab036. [PMID: 33885818 DOI: 10.1093/jpp/rgab036] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
53 Ehrenfeld V, Fulda S. Thioredoxin inhibitor PX-12 induces mitochondria-mediated apoptosis in acute lymphoblastic leukemia cells. Biol Chem 2020;401:273-83. [PMID: 31352431 DOI: 10.1515/hsz-2019-0160] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
54 Rajabi S, Maresca M, Yumashev AV, Choopani R, Hajimehdipoor H. The Most Competent Plant-Derived Natural Products for Targeting Apoptosis in Cancer Therapy. Biomolecules 2021;11. [PMID: 33916780 DOI: 10.3390/biom11040534] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
55 Micallef I, Baron B. The Mechanistic Roles of ncRNAs in Promoting and Supporting Chemoresistance of Colorectal Cancer. Noncoding RNA 2021;7:24. [PMID: 33807355 DOI: 10.3390/ncrna7020024] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
56 Babgi BA, Alsayari J, Alenezi HM, Abdellatif MH, Eltayeb NE, Emwas AM, Jaremko M, Hussien MA. Alteration of Anticancer and Protein-Binding Properties of Gold(I) Alkynyl by Phenolic Schiff Bases Moieties. Pharmaceutics 2021;13:461. [PMID: 33805337 DOI: 10.3390/pharmaceutics13040461] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
57 Cogswell DT, Gapin L, Tobin HM, McCarter MD, Tobin RP. MAIT Cells: Partners or Enemies in Cancer Immunotherapy? Cancers (Basel) 2021;13:1502. [PMID: 33805904 DOI: 10.3390/cancers13071502] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
58 Zhong Y, Lin H, Li Q, Liu C, Shen J. CircRNA_100565 contributes to cisplatin resistance of NSCLC cells by regulating proliferation, apoptosis and autophagy via miR-337-3p/ADAM28 axis. Cancer Biomark 2021;30:261-73. [PMID: 33682697 DOI: 10.3233/CBM-201705] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
59 Wang Y, Chen Y, Zhu B, Ma L, Xing Q. A Novel Nine Apoptosis-Related Genes Signature Predicting Overall Survival for Kidney Renal Clear Cell Carcinoma and its Associations with Immune Infiltration. Front Mol Biosci 2021;8:567730. [PMID: 33748185 DOI: 10.3389/fmolb.2021.567730] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
60 Zeng T, Yao L, Zhao K, Cong R, Meng X, Song N. Identification and validation of a five apoptosis-related genes signature for prediction of disease-free survival for testicular germ cell tumors. Transl Androl Urol 2021;10:1250-72. [PMID: 33850760 DOI: 10.21037/tau-20-1247] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
61 Fathima S, Sinha S, Donakonda S. Network Analysis Identifies Drug Targets and Small Molecules to Modulate Apoptosis Resistant Cancers. Cancers (Basel) 2021;13:851. [PMID: 33670487 DOI: 10.3390/cancers13040851] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
62 Liu X, Gu Y, Bian Y, Cai D, Li Y, Zhao Y, Zhang Z, Xue M, Zhang L. Honokiol induces paraptosis-like cell death of acute promyelocytic leukemia via mTOR & MAPK signaling pathways activation. Apoptosis 2021;26:195-208. [PMID: 33550458 DOI: 10.1007/s10495-020-01655-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
63 Orchel A, Chodurek E, Jaworska-Kik M, Paduszyński P, Kaps A, Chrobak E, Bębenek E, Boryczka S, Borkowska P, Kasperczyk J. Anticancer Activity of the Acetylenic Derivative of Betulin Phosphate Involves Induction of Necrotic-Like Death in Breast Cancer Cells In Vitro. Molecules 2021;26:615. [PMID: 33503929 DOI: 10.3390/molecules26030615] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
64 Simas Frauches N, Montenegro J, Amaral T, Abreu JP, Laiber G, Junior J, Borguini R, Santiago M, Pacheco S, Nakajima VM, Godoy R, Teodoro AJ. Antiproliferative Activity on Human Colon Adenocarcinoma Cells and In Vitro Antioxidant Effect of Anthocyanin-Rich Extracts from Peels of Species of the Myrtaceae Family. Molecules 2021;26:564. [PMID: 33498977 DOI: 10.3390/molecules26030564] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
65 Wende M, Sithole S, Chi GF, Stevens MY, Mukanganyama S. The Effects of Combining Cancer Drugs with Compounds Isolated from Combretum zeyheri Sond. and Combretum platypetalum Welw. ex M.A. Lawson (Combretaceae) on the Viability of Jurkat T Cells and HL-60 Cells. Biomed Res Int 2021;2021:6049728. [PMID: 33623782 DOI: 10.1155/2021/6049728] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
66 Battista S, Cerchia L, Fedele M. Molecular and cellular mechanisms in recurrent glioblastoma chemoresistance. Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies 2021. [DOI: 10.1016/b978-0-12-821567-8.00011-7] [Reference Citation Analysis]
67 Ramakrishna W, Kumari A, Rahman N, Mandave P. Anticancer Activities of Plant Secondary Metabolites: Rice Callus Suspension Culture as a New Paradigm. Rice Science 2021;28:13-30. [DOI: 10.1016/j.rsci.2020.11.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
68 Dilshara MG, Neelaka Molagoda IM, Prasad Tharanga Jayasooriya RG, Choi YH, Park C, Kim GY. Indirubin-3'-monoxime induces paraptosis in MDA-MB-231 breast cancer cells by transmitting Ca2+ from endoplasmic reticulum to mitochondria. Arch Biochem Biophys 2021;698:108723. [PMID: 33321111 DOI: 10.1016/j.abb.2020.108723] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
69 Cui G, Huang Y, Feng W, Yao Y, Zhou H, Li X, Gong H, Liu J, Luo Y, Sun Y, Zhang M, Luo Y, Zhang T. Colon cancer-associated transcript-1 enhances glucose metabolism and colon cancer cell activity in a high-glucose environment in vitro and in vivo. J Gastrointest Oncol 2020;11:1164-85. [PMID: 33456991 DOI: 10.21037/jgo-20-474] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
70 Wang R, Li Y, Dehaen W. Antiproliferative effect of mitochondria-targeting allobetulin 1,2,3-triazolium salt derivatives and their mechanism of inducing apoptosis of cancer cells. European Journal of Medicinal Chemistry 2020;207:112737. [DOI: 10.1016/j.ejmech.2020.112737] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
71 Son HK, Kim D, Lim Y, Kim J, Park I. A novel TGF-β receptor II mutation (I227T/N236D) promotes aggressive phenotype of oral squamous cell carcinoma via enhanced EGFR signaling. BMC Cancer 2020;20:1163. [PMID: 33246423 DOI: 10.1186/s12885-020-07669-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
72 Joshi PS, Patil DB, Chougule MS, Dudhanakar MP, Hongal BP, Agnihotri NS. Utility of DNA-Specific Stains in the Assessment of Apoptosis in Oral Exfoliated Buccal Cells of Tobacco Chewers and Patients with Oral Squamous Cell Carcinoma. jemds 2020;9:3351-3355. [DOI: 10.14260/jemds/2020/737] [Reference Citation Analysis]
73 Yu Z, Du J, Zhao Y, Gao Y, Li Y, Zhao K, Lu N. A novel kinase inhibitor, LZT-106, downregulates Mcl-1 and sensitizes colorectal cancer cells to BH3 mimetic ABT-199 by targeting CDK9 and GSK-3β signaling. Cancer Lett 2021;498:31-41. [PMID: 33129955 DOI: 10.1016/j.canlet.2020.10.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
74 Shoshan-Barmatz V, Shteinfer-Kuzmine A, Verma A. VDAC1 at the Intersection of Cell Metabolism, Apoptosis, and Diseases. Biomolecules 2020;10:E1485. [PMID: 33114780 DOI: 10.3390/biom10111485] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 16.0] [Reference Citation Analysis]
75 Alvarez-Meythaler JG, Garcia-Mayea Y, Mir C, Kondoh H, LLeonart ME. Autophagy Takes Center Stage as a Possible Cancer Hallmark. Front Oncol 2020;10:586069. [PMID: 33194736 DOI: 10.3389/fonc.2020.586069] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
76 Eustace NJ, Anderson JC, Warram JM, Widden HN, Pedersen RT, Alrefai H, Patel Z, Hicks PH, Placzek WJ, Gillespie GY, Hjelmeland AB, Willey CD. A cell-penetrating MARCKS mimetic selectively triggers cytolytic death in glioblastoma. Oncogene 2020;39:6961-74. [PMID: 33077834 DOI: 10.1038/s41388-020-01511-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
77 Hwang WC, Kang DW, Kang Y, Jang Y, Kim JA, Min DS. Inhibition of phospholipase D2 augments histone deacetylase inhibitor-induced cell death in breast cancer cells. Biol Res 2020;53:34. [PMID: 32998768 DOI: 10.1186/s40659-020-00294-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
78 Li Y, Gong P, Kong C, Tian X. Bufalin engages in RIP1-dependent and ROS-dependent programmed necroptosis in breast cancer cells by targeting the RIP1/RIP3/PGAM5 pathway. Anticancer Drugs 2019;30:e0770. [PMID: 30829654 DOI: 10.1097/CAD.0000000000000770] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
79 Xie Q, Liu Y, Li X. The interaction mechanism between autophagy and apoptosis in colon cancer. Transl Oncol 2020;13:100871. [PMID: 32950931 DOI: 10.1016/j.tranon.2020.100871] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 15.7] [Reference Citation Analysis]
80 Huang X, Chen Z, Ni F, Ye X, Qian W. Shikonin overcomes drug resistance and induces necroptosis by regulating the miR-92a-1-5p/MLKL axis in chronic myeloid leukemia. Aging (Albany NY) 2020;12:17662-80. [PMID: 32927433 DOI: 10.18632/aging.103844] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
81 Paul T, Banerjee A, Reddy SVB, Mahato SK, Biswas N. Hydroxychavicol sensitizes imatinib-resistant chronic myelogenous leukemia cells to TRAIL-induced apoptosis by ROS-mediated IAP downregulation. Anticancer Drugs 2019;30:167-78. [PMID: 30418193 DOI: 10.1097/CAD.0000000000000710] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
82 Qiu Y, Cao Y, Cao W, Jia Y, Lu N. The Application of Ferroptosis in Diseases. Pharmacological Research 2020;159:104919. [DOI: 10.1016/j.phrs.2020.104919] [Cited by in Crossref: 86] [Cited by in F6Publishing: 102] [Article Influence: 28.7] [Reference Citation Analysis]
83 Vaghari-Tabari M, Majidinia M, Moein S, Qujeq D, Asemi Z, Alemi F, Mohamadzadeh R, Targhazeh N, Safa A, Yousefi B. MicroRNAs and colorectal cancer chemoresistance: New solution for old problem. Life Sci 2020;259:118255. [PMID: 32818543 DOI: 10.1016/j.lfs.2020.118255] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 8.3] [Reference Citation Analysis]
84 Lee GY, Lee JS, Son CG, Lee NH. Combating Drug Resistance in Colorectal Cancer Using Herbal Medicines. Chin J Integr Med 2021;27:551-60. [PMID: 32740824 DOI: 10.1007/s11655-020-3425-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
85 Mu JK, Li YQ, Shi TT, Yu LP, Yang YQ, Gu W, Li JP, Yu J, Yang XX. Remedying the Mitochondria to Cure Human Diseases by Natural Products. Oxid Med Cell Longev 2020;2020:5232614. [PMID: 32733635 DOI: 10.1155/2020/5232614] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
86 Messeha SS, Zarmouh NO, Asiri A, Soliman KFA. Rosmarinic acid-induced apoptosis and cell cycle arrest in triple-negative breast cancer cells. Eur J Pharmacol 2020;885:173419. [PMID: 32750370 DOI: 10.1016/j.ejphar.2020.173419] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
87 Towers CG, Wodetzki D, Thorburn A. Autophagy and cancer: Modulation of cell death pathways and cancer cell adaptations. J Cell Biol 2020;219:e201909033. [PMID: 31753861 DOI: 10.1083/jcb.201909033] [Cited by in Crossref: 35] [Cited by in F6Publishing: 49] [Article Influence: 11.7] [Reference Citation Analysis]
88 Paneerselvam C, Ganapasam S. β-Escin alleviates cobalt chloride-induced hypoxia-mediated apoptotic resistance and invasion via ROS-dependent HIF-1α/TGF-β/MMPs in A549 cells. Toxicol Res (Camb) 2020;9:191-201. [PMID: 32670550 DOI: 10.1093/toxres/tfaa019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
89 Zhou J, Hou J, Rao J, Zhou C, Liu Y, Gao W. Magnetically Directed Enzyme/Prodrug Prostate Cancer Therapy Based on β-Glucosidase/Amygdalin. Int J Nanomedicine 2020;15:4639-57. [PMID: 32636623 DOI: 10.2147/IJN.S242359] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
90 Schwarz N, Tumpara S, Wrenger S, Ercetin E, Hamacher J, Welte T, Janciauskiene S. Alpha1-antitrypsin protects lung cancer cells from staurosporine-induced apoptosis: the role of bacterial lipopolysaccharide. Sci Rep 2020;10:9563. [PMID: 32533048 DOI: 10.1038/s41598-020-66825-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
91 Zinngrebe J, Schlichtig F, Kraus JM, Meyer M, Boldrin E, Kestler HA, Meyer L, Fischer‐posovszky P, Debatin K. Biomarker profile for prediction of response to SMAC mimetic monotherapy in pediatric precursor B‐cell acute lymphoblastic leukemia. Int J Cancer 2020;146:3219-31. [DOI: 10.1002/ijc.32799] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
92 Trager MH, Geskin LJ. Current status of histone deacetylase inhibitors in cutaneous T-cell lymphoma. G Ital Dermatol Venereol 2019;154:681-95. [PMID: 31859467 DOI: 10.23736/S0392-0488.19.06503-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
93 Lippmann J, Petri K, Fulda S, Liese J. Redox Modulation and Induction of Ferroptosis as a New Therapeutic Strategy in Hepatocellular Carcinoma. Transl Oncol 2020;13:100785. [PMID: 32416440 DOI: 10.1016/j.tranon.2020.100785] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
94 Abhari BA, McCarthy N, Agostinis P, Fulda S. NF-κB contributes to Smac mimetic-conferred protection from tunicamycin-induced apoptosis. Apoptosis 2019;24:269-77. [PMID: 30680482 DOI: 10.1007/s10495-018-1507-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
95 Haddad S, Abánades Lázaro I, Fantham M, Mishra A, Silvestre-Albero J, Osterrieth JWM, Kaminski Schierle GS, Kaminski CF, Forgan RS, Fairen-Jimenez D. Design of a Functionalized Metal-Organic Framework System for Enhanced Targeted Delivery to Mitochondria. J Am Chem Soc 2020;142:6661-74. [PMID: 32182066 DOI: 10.1021/jacs.0c00188] [Cited by in Crossref: 60] [Cited by in F6Publishing: 63] [Article Influence: 20.0] [Reference Citation Analysis]
96 Carneiro BA, El-Deiry WS. Targeting apoptosis in cancer therapy. Nat Rev Clin Oncol 2020;17:395-417. [PMID: 32203277 DOI: 10.1038/s41571-020-0341-y] [Cited by in Crossref: 488] [Cited by in F6Publishing: 539] [Article Influence: 162.7] [Reference Citation Analysis]
97 Iessi E, Marconi M, Manganelli V, Sorice M, Malorni W, Garofalo T, Matarrese P. On the role of sphingolipids in cell survival and death. Int Rev Cell Mol Biol 2020;351:149-95. [PMID: 32247579 DOI: 10.1016/bs.ircmb.2020.02.004] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
98 Ngoi NYL, Choong C, Lee J, Bellot G, Wong ALA, Goh BC, Pervaiz S. Targeting Mitochondrial Apoptosis to Overcome Treatment Resistance in Cancer. Cancers (Basel). 2020;12. [PMID: 32131385 DOI: 10.3390/cancers12030574] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 11.0] [Reference Citation Analysis]
99 Cullinane D, Gkika KS, Byrne A, Keyes TE. Photostable NIR emitting ruthenium(II) conjugates; uptake and biological activity in live cells. J Inorg Biochem 2020;207:111032. [PMID: 32311630 DOI: 10.1016/j.jinorgbio.2020.111032] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
100 Mora-Lagos B, Cartas-Espinel I, Riquelme I, Parker AC, Piccolo SR, Viscarra T, Reyes ME, Zanella L, Buchegger K, Ili C, Brebi P. Functional and transcriptomic characterization of cisplatin-resistant AGS and MKN-28 gastric cancer cell lines. PLoS One 2020;15:e0228331. [PMID: 31990955 DOI: 10.1371/journal.pone.0228331] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
101 Ogunsina M, Samadder P, Idowu T, Nachtigal M, Schweizer F, Arthur G. Syntheses of L-Rhamnose-Linked Amino Glycerolipids and Their Cytotoxic Activities against Human Cancer Cells. Molecules 2020;25:E566. [PMID: 32012953 DOI: 10.3390/molecules25030566] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
102 Milutinović M, Cvetković D. Anticancer Activity of Secondary Metabolites of Teucrium Species. Teucrium Species: Biology and Applications 2020. [DOI: 10.1007/978-3-030-52159-2_13] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
103 Mahomoodally MF, Ugurlu A, Llorent-martínez EJ, Nagamootoo M, Picot-allain MCN, Baloglu MC, Altunoglu YC, Hosenally M, Zengin G. Syzgium coriaceum Bosser & J. Guého—An endemic plant potentiates conventional antibiotics, inhibits clinical enzymes and induces apoptosis in breast cancer cells. Industrial Crops and Products 2020;143:111948. [DOI: 10.1016/j.indcrop.2019.111948] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
104 Gatadi S, Pulivendala G, Gour J, Malasala S, Bujji S, Parupalli R, Shaikh M, Godugu C, Nanduri S. Synthesis and evaluation of new 4(3H)-Quinazolinone derivatives as potential anticancer agents. Journal of Molecular Structure 2020;1200:127097. [DOI: 10.1016/j.molstruc.2019.127097] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
105 Klingebiel T, Bader P, Fulda S. Grundlagen der pädiatrischen Onkologie. Pädiatrie 2020. [DOI: 10.1007/978-3-662-60300-0_224] [Reference Citation Analysis]
106 Wang Q, Wang P, Zhang L, Tessema M, Bai L, Xu X, Li Q, Zheng X, Saxton B, Chen W, Willink R, Li Z, Zhang L, Belinsky SA, Wang X, Zhou B, Lin Y. Epigenetic Regulation of RIP3 Suppresses Necroptosis and Increases Resistance to Chemotherapy in NonSmall Cell Lung Cancer. Transl Oncol 2020;13:372-82. [PMID: 31887632 DOI: 10.1016/j.tranon.2019.11.011] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 5.3] [Reference Citation Analysis]
107 Imlimthan S, Correia A, Figueiredo P, Lintinen K, Balasubramanian V, Airaksinen AJ, Kostiainen MA, Santos HA, Sarparanta M. Systematic in vitro biocompatibility studies of multimodal cellulose nanocrystal and lignin nanoparticles. J Biomed Mater Res A 2020;108:770-83. [PMID: 31794149 DOI: 10.1002/jbm.a.36856] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
108 Sun J, Qian X, Zhang F, Tang X, Ju C, Liu R, Zhou R, Zhang Z, Lv XB, Zhang C, Huang G. HDAC6 inhibitor WT161 induces apoptosis in retinoblastoma cells and synergistically interacts with cisplatin. Transl Cancer Res 2019;8:2759-68. [PMID: 35117033 DOI: 10.21037/tcr.2019.10.30] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
109 Fernández-Delgado E, de la Cruz-Martínez F, Galán C, Franco L, Espino J, Viñuelas-Zahínos E, Luna-Giles F, Bejarano I. Pt(II) and Pd(II) complexes with a thiazoline derivative ligand: Synthesis, structural characterization, antiproliferative activity and evaluation of pro-apoptotic ability in tumor cell lines HT-29 and U-937. J Inorg Biochem 2020;202:110870. [PMID: 31689624 DOI: 10.1016/j.jinorgbio.2019.110870] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
110 Tortorelli GA, Torricelli C, Carron J, Costa EFD, Lopes-Aguiar L, Carvalho BF, Rinck-Junior JA, Mariano FV, Altemani AMAM, Lima CSP, Lourenço GJ. CASP8 (rs3834129) and CASP3 (rs4647601) polymorphisms in oropharynx cancer risk, tumor cell differentiation, and prognosis in a cohort of the Brazilian population. Mol Biol Rep 2019;46:6557-63. [PMID: 31587185 DOI: 10.1007/s11033-019-05107-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
111 Hashemi M, Zali A, Hashemi J, Oraee-Yazdani S, Akbari A. Down-regulation of 14-3-3 zeta sensitizes human glioblastoma cells to apoptosis induction. Apoptosis 2018;23:616-25. [PMID: 30101359 DOI: 10.1007/s10495-018-1476-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
112 Khanam R, Kumar R, Hejazi II, Shahabuddin S, Meena R, Jayant V, Kumar P, Bhat AR, Athar F. Piperazine clubbed with 2-azetidinone derivatives suppresses proliferation, migration and induces apoptosis in human cervical cancer HeLa cells through oxidative stress mediated intrinsic mitochondrial pathway. Apoptosis 2018;23:113-31. [PMID: 29349707 DOI: 10.1007/s10495-018-1439-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
113 Manasa KL, Saifi MA, Tangella Y, Godugu C, Alvala M. Synthesis of Substituted Cinnamido Linked Quinazolinone Congeners as Potential Anticancer Agents via Mitochondrial Dependent Intrinsic Apoptotic Pathway. Anticancer Agents Med Chem 2019;19:1935-48. [PMID: 31490766 DOI: 10.2174/1871520619666190906162537] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
114 Stevens M, Oltean S. Modulation of the Apoptosis Gene Bcl-x Function Through Alternative Splicing. Front Genet 2019;10:804. [PMID: 31552099 DOI: 10.3389/fgene.2019.00804] [Cited by in Crossref: 56] [Cited by in F6Publishing: 59] [Article Influence: 14.0] [Reference Citation Analysis]
115 Segat GC, Moreira CG, Santos EC, Heller M, Schwanke RC, Aksenov AV, Aksenov NA, Aksenov DA, Kornienko A, Marcon R, Calixto JB. A new series of acetohydroxamates shows in vitro and in vivo anticancer activity against melanoma. Invest New Drugs 2020;38:977-89. [DOI: 10.1007/s10637-019-00849-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
116 Yahya SM, Abdelnasser SM, Hamed AR, El Sayed OH, Asker MS. Newly isolated marine bacterial exopolysaccharides enhance antitumor activity in HepG2 cells via affecting key apoptotic factors and activating toll like receptors. Mol Biol Rep 2019;46:6231-41. [DOI: 10.1007/s11033-019-05061-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
117 Lv L, Lu J, Zhang H, Wang X, Su G, Piao H, Zhao Y. Acylation of 25-hydroxyprotopanaxatriol with aromatic acids increases cytotoxicity. Fitoterapia 2019;137:104279. [DOI: 10.1016/j.fitote.2019.104279] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
118 Meister MT, Boedicker C, Linder B, Kögel D, Klingebiel T, Fulda S. Concomitant targeting of Hedgehog signaling and MCL-1 synergistically induces cell death in Hedgehog-driven cancer cells. Cancer Lett 2019;465:1-11. [PMID: 31465840 DOI: 10.1016/j.canlet.2019.08.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
119 Li HY, Li P, Yang HG, Wang YZ, Huang GX, Wang JQ, Zheng N. Investigation and comparison of the anti-tumor activities of lactoferrin, α-lactalbumin, and β-lactoglobulin in A549, HT29, HepG2, and MDA231-LM2 tumor models. J Dairy Sci 2019;102:9586-97. [PMID: 31447140 DOI: 10.3168/jds.2019-16429] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
120 Lu J, Li X, Tu K, Guan Y, Fung KP, Liu F. Verticillin A suppresses HGF-induced migration and invasion via repression of the c-Met/FAK/Src pathway in human gastric and cervical cancer cells. Onco Targets Ther 2019;12:5823-33. [PMID: 31440058 DOI: 10.2147/OTT.S208683] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
121 Jiménez-Martínez Y, Griñán-Lisón C, Khaldy H, Martín A, Cambrils A, Ibáñez Grau A, Jiménez G, Marchal JA, Boulaiz H. LdrB Toxin with In Vitro and In Vivo Antitumor Activity as a Potential Tool for Cancer Gene Therapy. Cancers (Basel) 2019;11:E1016. [PMID: 31330822 DOI: 10.3390/cancers11071016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
122 Liu Y, Fan D. Ginsenoside Rg5 induces G2/M phase arrest, apoptosis and autophagy via regulating ROS-mediated MAPK pathways against human gastric cancer. Biochem Pharmacol 2019;168:285-304. [PMID: 31301277 DOI: 10.1016/j.bcp.2019.07.008] [Cited by in Crossref: 39] [Cited by in F6Publishing: 44] [Article Influence: 9.8] [Reference Citation Analysis]
123 Moradkhani F, Moloudizargari M, Fallah M, Asghari N, Heidari Khoei H, Asghari MH. Immunoregulatory role of melatonin in cancer. J Cell Physiol 2020;235:745-57. [PMID: 31270813 DOI: 10.1002/jcp.29036] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 10.0] [Reference Citation Analysis]
124 Huang W, Guo L, Zhao M, Zhang D, Xu H, Nie Q. The Inhibition on MDFIC and PI3K/AKT Pathway Caused by miR-146b-3p Triggers Suppression of Myoblast Proliferation and Differentiation and Promotion of Apoptosis. Cells 2019;8:E656. [PMID: 31261950 DOI: 10.3390/cells8070656] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 6.3] [Reference Citation Analysis]
125 García-Aranda M, Redondo M. Targeting Protein Kinases to Enhance the Response to anti-PD-1/PD-L1 Immunotherapy. Int J Mol Sci 2019;20:E2296. [PMID: 31075880 DOI: 10.3390/ijms20092296] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 6.8] [Reference Citation Analysis]
126 Fu L, Wang X, Zhai J, Qi W, Jing L, Ge Y, Gao X, Liu C, Lv X, Zheng S. Changes in apoptosis, proliferation and T lymphocyte subtype on thymic cells of SPF chickens infected with reticuloendotheliosis virus. Mol Immunol 2019;111:87-94. [PMID: 31048099 DOI: 10.1016/j.molimm.2019.04.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
127 Yang L, Kumar B, Shen C, Zhao S, Blakaj D, Li T, Romito M, Teknos TN, Williams TM. LCL161, a SMAC-mimetic, Preferentially Radiosensitizes Human Papillomavirus-negative Head and Neck Squamous Cell Carcinoma. Mol Cancer Ther 2019;18:1025-35. [PMID: 31015310 DOI: 10.1158/1535-7163.MCT-18-1157] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
128 Niazvand F, Orazizadeh M, Khorsandi L, Abbaspour M, Mansouri E, Khodadadi A. Effects of Quercetin-Loaded Nanoparticles on MCF-7 Human Breast Cancer Cells. Medicina (Kaunas) 2019;55:E114. [PMID: 31013662 DOI: 10.3390/medicina55040114] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 12.8] [Reference Citation Analysis]
129 Zahavi DJ, Weiner LM. Tumor mechanisms of resistance to immune attack. Prog Mol Biol Transl Sci 2019;164:61-100. [PMID: 31383409 DOI: 10.1016/bs.pmbts.2019.03.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
130 Ouchida AT, Uyemura VT, Queiroz AL, Brauer VS, Cavalcanti-neto MP, Sousa LO, Uyemura SA, Curti C, Leopoldino AM. SET protein accumulation prevents cell death in head and neck squamous cell carcinoma through regulation of redox state and autophagy. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2019;1866:623-37. [DOI: 10.1016/j.bbamcr.2019.01.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
131 Gong P, Wang Y, Jing Y. Apoptosis Induction byHistone Deacetylase Inhibitors in Cancer Cells: Role of Ku70. Int J Mol Sci 2019;20:E1601. [PMID: 30935057 DOI: 10.3390/ijms20071601] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
132 Jameel F, Agarwal P, Arshad M, Serajuddin M. Omega-3 polyunsaturated fatty acids of fish and their role in cancerous cell lines: A review of in-vitro studies. Fisheries & Aquatic Life 2019;27:47-63. [DOI: 10.2478/aopf-2019-0006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
133 Liu M, Liu B, Liu Q, Du K, Wang Z, He N. Nanomaterial-induced ferroptosis for cancer specific therapy. Coordination Chemistry Reviews 2019;382:160-80. [DOI: 10.1016/j.ccr.2018.12.015] [Cited by in Crossref: 82] [Cited by in F6Publishing: 86] [Article Influence: 20.5] [Reference Citation Analysis]
134 Beberok A, Rzepka Z, Respondek M, Rok J, Stradowski M, Wrześniok D. Moxifloxacin as an inducer of apoptosis in melanoma cells: A study at the cellular and molecular level. Toxicology in Vitro 2019;55:75-92. [DOI: 10.1016/j.tiv.2018.12.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
135 Ramos J, Muthukumaran J, Freire F, Paquete-Ferreira J, Otrelo-Cardoso AR, Svergun D, Panjkovich A, Santos-Silva T. Shedding Light on the Interaction of Human Anti-Apoptotic Bcl-2 Protein with Ligands through Biophysical and in Silico Studies. Int J Mol Sci 2019;20:E860. [PMID: 30781512 DOI: 10.3390/ijms20040860] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
136 Frank T, Tuppi M, Hugle M, Dötsch V, van Wijk SJL, Fulda S. Cell cycle arrest in mitosis promotes interferon-induced necroptosis. Cell Death Differ 2019;26:2046-60. [PMID: 30742091 DOI: 10.1038/s41418-019-0298-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 6.5] [Reference Citation Analysis]
137 Chao D, Pang L, Shi Y, Wang W, Liu K. AZD3759 induces apoptosis in hepatoma cells by activating a p53-SMAD4 positive feedback loop. Biochemical and Biophysical Research Communications 2019;509:535-40. [DOI: 10.1016/j.bbrc.2018.12.102] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
138 Yun D, Wang H, Wang Y, Chen Y, Zhao Z, Ma J, Ji Y, Huang Q, Chen J, Chen H, Lu D. Shuttling SLC2A4RG is regulated by 14-3-3θ to modulate cell survival via caspase-3 and caspase-6 in human glioma. EBioMedicine 2019;40:163-75. [PMID: 30686753 DOI: 10.1016/j.ebiom.2019.01.030] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
139 Mortezaee K, Salehi E, Mirtavoos-Mahyari H, Motevaseli E, Najafi M, Farhood B, Rosengren RJ, Sahebkar A. Mechanisms of apoptosis modulation by curcumin: Implications for cancer therapy. J Cell Physiol 2019;234:12537-50. [PMID: 30623450 DOI: 10.1002/jcp.28122] [Cited by in Crossref: 129] [Cited by in F6Publishing: 140] [Article Influence: 32.3] [Reference Citation Analysis]
140 Klingebiel T, Bader P, Fulda S. Grundlagen der pädiatrischen Onkologie. Pädiatrie 2019. [DOI: 10.1007/978-3-642-54671-6_224-2] [Reference Citation Analysis]
141 Wang H, Zhang X. Apoptosis Imaging. Nuclear Medicine in Oncology 2019. [DOI: 10.1007/978-981-13-7458-6_14] [Reference Citation Analysis]
142 Jarman PJ, Noakes F, Fairbanks S, Smitten K, Griffiths IK, Saeed HK, Thomas JA, Smythe C. Exploring the Cytotoxicity, Uptake, Cellular Response, and Proteomics of Mono- and Dinuclear DNA Light-Switch Complexes. J Am Chem Soc 2019;141:2925-37. [DOI: 10.1021/jacs.8b09999] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 8.2] [Reference Citation Analysis]
143 Huang X, Xiao F, Li Y, Qian W, Ding W, Ye X. Bypassing drug resistance by triggering necroptosis: recent advances in mechanisms and its therapeutic exploitation in leukemia. J Exp Clin Cancer Res 2018;37:310. [PMID: 30541583 DOI: 10.1186/s13046-018-0976-z] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
144 Lopez AT, Bates S, Geskin L. Current Status of HDAC Inhibitors in Cutaneous T-cell Lymphoma. Am J Clin Dermatol 2018;19:805-19. [PMID: 30173294 DOI: 10.1007/s40257-018-0380-7] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
145 Apidi E, Wan Taib WR, Hassan R, Ab Mutalib NS, Ismail I. A review on effect of genetic features on treatment responses in acute myeloid leukemia. Meta Gene 2018;18:31-38. [DOI: 10.1016/j.mgene.2018.07.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
146 Wang M, Liu G, Li H. Extraction of matrine from Sophora flavescens Ait. and evaluation of its inhibitory effects on human nasopharyngeal carcinoma CNE-2 cells. Food Sci Technol 2018;38:333-7. [DOI: 10.1590/fst.24117] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
147 De Vitto H, Palorini R, Votta G, Chiaradonna F. Mitochondria in Focus: Targeting the Cell-Death Mechanism. Apoptosis and Beyond 2018. [DOI: 10.1002/9781119432463.ch2] [Reference Citation Analysis]
148 Kumar Y, Phaniendra A, Periyasamy L. Bixin Triggers Apoptosis of Human Hep3B Hepatocellular Carcinoma Cells: An Insight to Molecular and IN SILICO Approach. Nutr Cancer 2018;70:971-83. [PMID: 30204479 DOI: 10.1080/01635581.2018.1490445] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
149 Pang L, Liu K. Tumor-suppressing effects of autophagy on hepatocellular carcinoma. Liver Research 2018;2:157-60. [DOI: 10.1016/j.livres.2018.08.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
150 Saraei R, Soleimani M, Movassaghpour Akbari AA, Farshdousti Hagh M, Hassanzadeh A, Solali S. The role of XIAP in resistance to TNF-related apoptosis-inducing ligand (TRAIL) in Leukemia. Biomed Pharmacother 2018;107:1010-9. [PMID: 30257312 DOI: 10.1016/j.biopha.2018.08.065] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
151 Beberok A, Rzepka Z, Respondek M, Rok J, Sierotowicz D, Wrześniok D. GSH depletion, mitochondrial membrane breakdown, caspase-3/7 activation and DNA fragmentation in U87MG glioblastoma cells: New insight into the mechanism of cytotoxicity induced by fluoroquinolones. Eur J Pharmacol 2018;835:94-107. [PMID: 30086267 DOI: 10.1016/j.ejphar.2018.08.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
152 Chow MJ, Babak MV, Tan KW, Cheong MC, Pastorin G, Gaiddon C, Ang WH. Induction of the Endoplasmic Reticulum Stress Pathway by Highly Cytotoxic Organoruthenium Schiff-Base Complexes. Mol Pharm 2018;15:3020-31. [PMID: 29979603 DOI: 10.1021/acs.molpharmaceut.8b00003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 5.2] [Reference Citation Analysis]
153 Ridinger J, Koeneke E, Kolbinger FR, Koerholz K, Mahboobi S, Hellweg L, Gunkel N, Miller AK, Peterziel H, Schmezer P, Hamacher-Brady A, Witt O, Oehme I. Dual role of HDAC10 in lysosomal exocytosis and DNA repair promotes neuroblastoma chemoresistance. Sci Rep 2018;8:10039. [PMID: 29968769 DOI: 10.1038/s41598-018-28265-5] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 5.8] [Reference Citation Analysis]
154 Behboodi S, Baghbani-Arani F, Abdalan S, Sadat Shandiz SA. Green Engineered Biomolecule-Capped Silver Nanoparticles Fabricated from Cichorium intybus Extract: In Vitro Assessment on Apoptosis Properties Toward Human Breast Cancer (MCF-7) Cells. Biol Trace Elem Res 2019;187:392-402. [PMID: 29808275 DOI: 10.1007/s12011-018-1392-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
155 Zhang Y, Mi X, Song Z, Li Y, YingShi, Niu J. Cripto-1 promotes resistance to drug-induced apoptosis by activating the TAK-1/NF-κB/survivin signaling pathway. Biomed Pharmacother 2018;104:729-37. [PMID: 29807222 DOI: 10.1016/j.biopha.2018.05.063] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
156 Meister MT, Boedicker C, Klingebiel T, Fulda S. Hedgehog signaling negatively co-regulates BH3-only protein Noxa and TAp73 in TP53-mutated cells. Cancer Lett 2018;429:19-28. [PMID: 29702195 DOI: 10.1016/j.canlet.2018.04.025] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
157 Engert F, Kovac M, Baumhoer D, Nathrath M, Fulda S. Osteosarcoma cells with genetic signatures of BRCAness are susceptible to the PARP inhibitor talazoparib alone or in combination with chemotherapeutics. Oncotarget 2017;8:48794-806. [PMID: 27447864 DOI: 10.18632/oncotarget.10720] [Cited by in Crossref: 56] [Cited by in F6Publishing: 60] [Article Influence: 11.2] [Reference Citation Analysis]
158 Dächert J, Schoeneberger H, Rohde K, Fulda S. RSL3 and Erastin differentially regulate redox signaling to promote Smac mimetic-induced cell death. Oncotarget 2016;7:63779-92. [PMID: 27588473 DOI: 10.18632/oncotarget.11687] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 7.2] [Reference Citation Analysis]
159 Sri Ramya P, Guntuku L, Angapelly S, Karri S, Digwal CS, Babu BN, Naidu V, Kamal A. Curcumin inspired 2-chloro/phenoxy quinoline analogues: Synthesis and biological evaluation as potential anticancer agents. Bioorganic & Medicinal Chemistry Letters 2018;28:892-8. [DOI: 10.1016/j.bmcl.2018.01.070] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
160 Asghari MH, Ghobadi E, Moloudizargari M, Fallah M, Abdollahi M. Does the use of melatonin overcome drug resistance in cancer chemotherapy? Life Sciences 2018;196:143-55. [DOI: 10.1016/j.lfs.2018.01.024] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 7.2] [Reference Citation Analysis]
161 Lueck SC, Russ AC, Botzenhardt U, Schlenk RF, Zobel K, Deshayes K, Vucic D, Döhner H, Döhner K, Fulda S, Bullinger L. Smac mimetic induces cell death in a large proportion of primary acute myeloid leukemia samples, which correlates with defined molecular markers. Oncotarget 2016;7:49539-51. [PMID: 27385100 DOI: 10.18632/oncotarget.10390] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
162 Fang WB, Yao M, Brummer G, Acevedo D, Alhakamy N, Berkland C, Cheng N. Targeted gene silencing of CCL2 inhibits triple negative breast cancer progression by blocking cancer stem cell renewal and M2 macrophage recruitment. Oncotarget 2016;7:49349-67. [PMID: 27283985 DOI: 10.18632/oncotarget.9885] [Cited by in Crossref: 65] [Cited by in F6Publishing: 77] [Article Influence: 13.0] [Reference Citation Analysis]
163 Placet M, Arguin G, Molle CM, Babeu JP, Jones C, Carrier JC, Robaye B, Geha S, Boudreau F, Gendron FP. The G protein-coupled P2Y₆ receptor promotes colorectal cancer tumorigenesis by inhibiting apoptosis. Biochim Biophys Acta Mol Basis Dis 2018;1864:1539-51. [PMID: 29454075 DOI: 10.1016/j.bbadis.2018.02.008] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
164 Sievers D, Bunzendahl J, Frosch A, Perske C, Hemmerlein B, Schliephake H, Brockmeyer P. Generation of highly differentiated BHY oral squamous cell carcinoma multicellular spheroids. Mol Clin Oncol 2018;8:323-5. [PMID: 29435298 DOI: 10.3892/mco.2017.1514] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
165 Sun Y, Haglund TA, Rogers AJ, Ghanim AF, Sethu P. Review: Microfluidics technologies for blood-based cancer liquid biopsies. Anal Chim Acta 2018;1012:10-29. [PMID: 29475470 DOI: 10.1016/j.aca.2017.12.050] [Cited by in Crossref: 59] [Cited by in F6Publishing: 63] [Article Influence: 11.8] [Reference Citation Analysis]
166 Rajavel T, Packiyaraj P, Suryanarayanan V, Singh SK, Ruckmani K, Pandima Devi K. β-Sitosterol targets Trx/Trx1 reductase to induce apoptosis in A549 cells via ROS mediated mitochondrial dysregulation and p53 activation. Sci Rep 2018;8:2071. [PMID: 29391428 DOI: 10.1038/s41598-018-20311-6] [Cited by in Crossref: 45] [Cited by in F6Publishing: 54] [Article Influence: 9.0] [Reference Citation Analysis]
167 Fulda S. Cell death-based treatment of glioblastoma. Cell Death Dis 2018;9:121. [PMID: 29371590 DOI: 10.1038/s41419-017-0021-8] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 6.6] [Reference Citation Analysis]
168 Lu Y, Sun Y, Zhu J, Yu L, Jiang X, Zhang J, Dong X, Ma B, Zhang Q. Oridonin exerts anticancer effect on osteosarcoma by activating PPAR-γ and inhibiting Nrf2 pathway. Cell Death Dis 2018;9:15. [PMID: 29323103 DOI: 10.1038/s41419-017-0031-6] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 9.6] [Reference Citation Analysis]
169 Goto RN, Sobral LM, Sousa LO, Garcia CB, Lopes NP, Marín-prida J, Ochoa-rodríguez E, Verdecia-reyes Y, Pardo-andreu GL, Curti C, Leopoldino AM. Anti-cancer activity of a new dihydropyridine derivative, VdiE-2N, in head and neck squamous cell carcinoma. European Journal of Pharmacology 2018;819:198-206. [DOI: 10.1016/j.ejphar.2017.12.009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
170 Mejía C, Ortega-rosales S, Ruiz-azuara L. Mechanism of Action of Anticancer Metallodrugs. Biomedical Applications of Metals 2018. [DOI: 10.1007/978-3-319-74814-6_10] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
171 Yoshimori A, Tanuma S. Molecular Designing of Small-Molecule Inhibitors for Apoptosis Regulation. Current Human Cell Research and Applications 2018. [DOI: 10.1007/978-981-10-7296-3_10] [Reference Citation Analysis]
172 Fulda S. Therapeutic opportunities based on caspase modulation. Semin Cell Dev Biol 2018;82:150-7. [PMID: 29247787 DOI: 10.1016/j.semcdb.2017.12.008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
173 McComb S, Aguadé-Gorgorió J, Harder L, Marovca B, Cario G, Eckert C, Schrappe M, Stanulla M, von Stackelberg A, Bourquin JP, Bornhauser BC. Activation of concurrent apoptosis and necroptosis by SMAC mimetics for the treatment of refractory and relapsed ALL. Sci Transl Med 2016;8:339ra70. [PMID: 27194728 DOI: 10.1126/scitranslmed.aad2986] [Cited by in Crossref: 70] [Cited by in F6Publishing: 74] [Article Influence: 11.7] [Reference Citation Analysis]
174 Cekay MJ, Roesler S, Frank T, Knuth A, Eckhardt I, Fulda S. Smac mimetics and type II interferon synergistically induce necroptosis in various cancer cell lines. Cancer Letters 2017;410:228-37. [DOI: 10.1016/j.canlet.2017.09.002] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 4.5] [Reference Citation Analysis]
175 Zhang M, Xin W, Yi Z, Li Y, Liu Y, Zhang H, Chen H, Chen X, Tan S, Zhu D. Human biliverdin reductase regulates the molecular mechanism underlying cancer development. J Cell Biochem 2018;119:1337-45. [DOI: 10.1002/jcb.26285] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
176 Pistritto G, Trisciuoglio D, Ceci C, Garufi A, D'Orazi G. Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies. Aging (Albany NY). 2016;8:603-619. [PMID: 27019364 DOI: 10.18632/aging.100934] [Cited by in Crossref: 607] [Cited by in F6Publishing: 676] [Article Influence: 101.2] [Reference Citation Analysis]
177 Ma T, Lu C, Guo Y, Zhang C, Du X. Human U3 protein 14a plays an anti-apoptotic role in cancer cells. Biol Chem 2017;398:1247-57. [PMID: 28672776 DOI: 10.1515/hsz-2017-0121] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
178 Alsalawy NF, Darwish RK, Kamal MM, ElTaweel AE, Shousha HI, Elbaz TM. Evaluation of trail receptor 1 (DR4) polymorphisms C626G and A683C as risk factors of hepatocellular carcinoma. J Med Virol 2018;90:490-6. [PMID: 28975649 DOI: 10.1002/jmv.24964] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
179 Boroumand Moghaddam A, Moniri M, Azizi S, Abdul Rahim R, Bin Ariff A, Navaderi M, Mohamad R. Eco-Friendly Formulated Zinc Oxide Nanoparticles: Induction of Cell Cycle Arrest and Apoptosis in the MCF-7 Cancer Cell Line. Genes (Basel) 2017;8:E281. [PMID: 29053567 DOI: 10.3390/genes8100281] [Cited by in Crossref: 63] [Cited by in F6Publishing: 70] [Article Influence: 10.5] [Reference Citation Analysis]
180 Habermann KJ, Grünewald L, van Wijk S, Fulda S. Targeting redox homeostasis in rhabdomyosarcoma cells: GSH-depleting agents enhance auranofin-induced cell death. Cell Death Dis 2017;8:e3067. [PMID: 28981107 DOI: 10.1038/cddis.2017.412] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 5.5] [Reference Citation Analysis]
181 Shoshan-Barmatz V, Maldonado EN, Krelin Y. VDAC1 at the crossroads of cell metabolism, apoptosis and cell stress. Cell Stress 2017;1:11-36. [PMID: 30542671 DOI: 10.15698/cst2017.10.104] [Cited by in Crossref: 69] [Cited by in F6Publishing: 74] [Article Influence: 11.5] [Reference Citation Analysis]
182 Li Q, Peng J, Liu T, Zhang G. Effects of celecoxib on cell apoptosis and Fas, FasL and Bcl-2 expression in a BGC-823 human gastric cancer cell line. Exp Ther Med 2017;14:1935-40. [PMID: 28962106 DOI: 10.3892/etm.2017.4769] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
183 Nazim UM, Rasheduzzaman M, Lee YJ, Seol DW, Park SY. Enhancement of TRAIL-induced apoptosis by 5-fluorouracil requires activating Bax and p53 pathways in TRAIL-resistant lung cancers. Oncotarget 2017;8:18095-105. [PMID: 28178647 DOI: 10.18632/oncotarget.14994] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
184 Chen Y, Zhu L, Yang X, Wei C, Chen C, He Y, Ji Z. Ailanthone induces G2/M cell cycle arrest and apoptosis of SGC‑7901 human gastric cancer cells. Mol Med Rep 2017;16:6821-7. [PMID: 28901518 DOI: 10.3892/mmr.2017.7491] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
185 Onyeagucha B, Subbarayalu P, Abdelfattah N, Rajamanickam S, Timilsina S, Guzman R, Zeballos C, Eedunuri V, Bansal S, Mohammad T, Chen Y, Vadlamudi RK, Rao MK. Novel post-transcriptional and post-translational regulation of pro-apoptotic protein BOK and anti-apoptotic protein Mcl-1 determine the fate of breast cancer cells to survive or die. Oncotarget 2017;8:85984-96. [PMID: 29156771 DOI: 10.18632/oncotarget.20841] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
186 Pan ST, Li ZL, He ZX, Qiu JX, Zhou SF. Molecular mechanisms for tumour resistance to chemotherapy. Clin Exp Pharmacol Physiol 2016;43:723-37. [PMID: 27097837 DOI: 10.1111/1440-1681.12581] [Cited by in Crossref: 222] [Cited by in F6Publishing: 238] [Article Influence: 37.0] [Reference Citation Analysis]
187 Probst L, Dächert J, Schenk B, Fulda S. Lipoxygenase inhibitors protect acute lymphoblastic leukemia cells from ferroptotic cell death. Biochemical Pharmacology 2017;140:41-52. [DOI: 10.1016/j.bcp.2017.06.112] [Cited by in Crossref: 70] [Cited by in F6Publishing: 74] [Article Influence: 11.7] [Reference Citation Analysis]
188 Mármol I, Virumbrales-Muñoz M, Quero J, Sánchez-de-Diego C, Fernández L, Ochoa I, Cerrada E, Yoldi MJR. Alkynyl gold(I) complex triggers necroptosis via ROS generation in colorectal carcinoma cells. J Inorg Biochem 2017;176:123-33. [PMID: 28892675 DOI: 10.1016/j.jinorgbio.2017.08.020] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 8.7] [Reference Citation Analysis]
189 Carter CA, Oronsky BT, Roswarski J, Oronsky AL, Oronsky N, Scicinski J, Lybeck H, Kim MM, Lybeck M, Reid TR. No patient left behind: The promise of immune priming with epigenetic agents. Oncoimmunology 2017;6:e1315486. [PMID: 29123948 DOI: 10.1080/2162402X.2017.1315486] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
190 Khanam R, Ahmad K, Hejazi II, Siddique IA, Kumar V, Bhat AR, Azam A, Athar F. Inhibitory growth evaluation and apoptosis induction in MCF-7 cancer cells by new 5-aryl-2-butylthio-1,3,4-oxadiazole derivatives. Cancer Chemother Pharmacol 2017;80:1027-42. [DOI: 10.1007/s00280-017-3414-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
191 Teymournejad O, Mobarez AM, Hassan ZM, Talebi Bezmin Abadi A. Binding of the Helicobacter pylori OipA causes apoptosis of host cells via modulation of Bax/Bcl-2 levels. Sci Rep 2017;7:8036. [PMID: 28808292 DOI: 10.1038/s41598-017-08176-7] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 5.0] [Reference Citation Analysis]
192 Hong H, An JC, de La Cruz JF, Hwang SG. Cnidium officinale Makino extract induces apoptosis through activation of caspase-3 and p53 in human liver cancer HepG2 cells. Exp Ther Med 2017;14:3191-7. [PMID: 28966688 DOI: 10.3892/etm.2017.4916] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
193 Tantak MP, Klingler L, Arun V, Kumar A, Sadana R, Kumar D. Design and synthesis of bis(indolyl)ketohydrazide-hydrazones: Identification of potent and selective novel tubulin inhibitors. European Journal of Medicinal Chemistry 2017;136:184-94. [DOI: 10.1016/j.ejmech.2017.04.078] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 5.2] [Reference Citation Analysis]
194 Wan D, Tang B, Wang YJ, Guo BH, Yin H, Yi QY, Liu YJ. Synthesis and anticancer properties of ruthenium (II) complexes as potent apoptosis inducers through mitochondrial disruption. Eur J Med Chem 2017;139:180-90. [PMID: 28800456 DOI: 10.1016/j.ejmech.2017.07.066] [Cited by in Crossref: 71] [Cited by in F6Publishing: 67] [Article Influence: 11.8] [Reference Citation Analysis]
195 Liu PF, Hu YC, Kang BH, Tseng YK, Wu PC, Liang CC, Hou YY, Fu TY, Liou HH, Hsieh IC, Ger LP, Shu CW. Expression levels of cleaved caspase-3 and caspase-3 in tumorigenesis and prognosis of oral tongue squamous cell carcinoma. PLoS One 2017;12:e0180620. [PMID: 28700659 DOI: 10.1371/journal.pone.0180620] [Cited by in Crossref: 40] [Cited by in F6Publishing: 45] [Article Influence: 6.7] [Reference Citation Analysis]
196 Kurt IC, Sur I, Kaya E, Cingoz A, Kazancioglu S, Kahya Z, Toparlak OD, Senbabaoglu F, Kaya Z, Ozyerli E, Karahüseyinoglu S, Lack NA, Gümüs ZH, Onder TT, Bagci-Onder T. KDM2B, an H3K36-specific demethylase, regulates apoptotic response of GBM cells to TRAIL. Cell Death Dis 2017;8:e2897. [PMID: 28661478 DOI: 10.1038/cddis.2017.288] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
197 Yan X, Li Q, Ni D, Xie Y, He Q, Wan Q, Liu Y, Lyu Z, Mao Z, Zhou Q. Apobec-1 complementation factor regulates cell migration and apoptosis through Dickkopf1 by acting on its 3′ untranslated region in MCF7 cells. Tumour Biol 2017;39:101042831770621. [DOI: 10.1177/1010428317706218] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
198 Wang H, Huwaimel B, Verma K, Miller J, Germain TM, Kinarivala N, Pappas D, Brookes PS, Trippier PC. Synthesis and Antineoplastic Evaluation of Mitochondrial Complex II (Succinate Dehydrogenase) Inhibitors Derived from Atpenin A5. ChemMedChem 2017;12:1033-44. [PMID: 28523727 DOI: 10.1002/cmdc.201700196] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 5.2] [Reference Citation Analysis]
199 Okumu DO, East MP, Levine M, Herring LE, Zhang R, Gilbert TSK, Litchfield DW, Zhang Y, Graves LM. BIRC6 mediates imatinib resistance independently of Mcl-1. PLoS One 2017;12:e0177871. [PMID: 28520795 DOI: 10.1371/journal.pone.0177871] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
200 Chowdhury SR, Ray U, Chatterjee BP, Roy SS. Targeted apoptosis in ovarian cancer cells through mitochondrial dysfunction in response to Sambucus nigra agglutinin. Cell Death Dis 2017;8:e2762. [PMID: 28471452 DOI: 10.1038/cddis.2017.77] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 6.0] [Reference Citation Analysis]
201 Hu T, Li Z, Gao CY, Cho CH. Mechanisms of drug resistance in colon cancer and its therapeutic strategies. World J Gastroenterol. 2016;22:6876-6889. [PMID: 27570424 DOI: 10.3748/wjg.vss.i30.6876] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
202 Liu K, Lin D, Ouyang Y, Pang L, Guo X, Wang S, Zang Y, Chen D. Amphiregulin impairs apoptosis-stimulating protein 2 of p53 overexpression-induced apoptosis in hepatoma cells. Tumour Biol 2017;39:1010428317695026. [PMID: 28351301 DOI: 10.1177/1010428317695026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
203 Kędzierska H, Piekiełko-Witkowska A. Splicing factors of SR and hnRNP families as regulators of apoptosis in cancer. Cancer Lett 2017;396:53-65. [PMID: 28315432 DOI: 10.1016/j.canlet.2017.03.013] [Cited by in Crossref: 106] [Cited by in F6Publishing: 103] [Article Influence: 17.7] [Reference Citation Analysis]
204 Fischer K, Tognarelli S, Roesler S, Boedicker C, Schubert R, Steinle A, Klingebiel T, Bader P, Fulda S, Ullrich E. The Smac Mimetic BV6 Improves NK Cell-Mediated Killing of Rhabdomyosarcoma Cells by Simultaneously Targeting Tumor and Effector Cells. Front Immunol 2017;8:202. [PMID: 28326081 DOI: 10.3389/fimmu.2017.00202] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
205 Nguyen PN, Huang CJ, Sugii S, Cheong SK, Choo KB. Selective activation of miRNAs of the primate-specific chromosome 19 miRNA cluster (C19MC) in cancer and stem cells and possible contribution to regulation of apoptosis. J Biomed Sci 2017;24:20. [PMID: 28270145 DOI: 10.1186/s12929-017-0326-z] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 5.3] [Reference Citation Analysis]
206 Chow MJ, Alfiean M, Pastorin G, Gaiddon C, Ang WH. Apoptosis-independent organoruthenium anticancer complexes that overcome multidrug resistance: self-assembly and phenotypic screening strategies. Chem Sci 2017;8:3641-9. [PMID: 30155208 DOI: 10.1039/c7sc00497d] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 5.2] [Reference Citation Analysis]
207 Sun J, Jiang L, Lin Y, Gerhard EM, Jiang X, Li L, Yang J, Gu Z. Enhanced anticancer efficacy of paclitaxel through multistage tumor-targeting liposomes modified with RGD and KLA peptides. Int J Nanomedicine 2017;12:1517-37. [PMID: 28280323 DOI: 10.2147/IJN.S122859] [Cited by in Crossref: 46] [Cited by in F6Publishing: 50] [Article Influence: 7.7] [Reference Citation Analysis]
208 Eldehna WM, Almahli H, Al-Ansary GH, Ghabbour HA, Aly MH, Ismael OE, Al-Dhfyan A, Abdel-Aziz HA. Synthesis and in vitro anti-proliferative activity of some novel isatins conjugated with quinazoline/phthalazine hydrazines against triple-negative breast cancer MDA-MB-231 cells as apoptosis-inducing agents. J Enzyme Inhib Med Chem 2017;32:600-13. [PMID: 28173708 DOI: 10.1080/14756366.2017.1279155] [Cited by in Crossref: 57] [Cited by in F6Publishing: 54] [Article Influence: 9.5] [Reference Citation Analysis]
209 Fulda S. Smac Mimetics to Therapeutically Target IAP Proteins in Cancer. Int Rev Cell Mol Biol 2017;330:157-69. [PMID: 28215531 DOI: 10.1016/bs.ircmb.2016.09.004] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 7.2] [Reference Citation Analysis]
210 Chellappa S, Aandahl EM, Taskén K. Cancer Immunity and Immune Evasion Mechanisms. Biomarkers of the Tumor Microenvironment 2017. [DOI: 10.1007/978-3-319-39147-2_8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
211 Mahdavi M, Dianat S, Khavari B, Moghimi S, Abdollahi M, Safavi M, Mouradzadegun A, Kabudanian Ardestani S, Sabourian R, Emami S, Akbarzadeh T, Shafiee A, Foroumadi A. Synthesis and biological evaluation of novel imidazopyrimidin-3-amines as anticancer agents. Chem Biol Drug Des 2017;89:797-805. [DOI: 10.1111/cbdd.12904] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
212 Wang W, Wang D, Wang Z, Yao G, Li X, Gao P, Li L, Zhang Y, Wang S, Song S. Synthesis of new sarsasapogenin derivatives with cytotoxicity and apoptosis-inducing activities in human breast cancer MCF-7 cells. Eur J Med Chem 2017;127:62-71. [PMID: 28038327 DOI: 10.1016/j.ejmech.2016.12.011] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
213 Rohde K, Kleinesudeik L, Roesler S, Löwe O, Heidler J, Schröder K, Wittig I, Dröse S, Fulda S. A Bak-dependent mitochondrial amplification step contributes to Smac mimetic/glucocorticoid-induced necroptosis. Cell Death Differ 2017;24:83-97. [PMID: 27834956 DOI: 10.1038/cdd.2016.102] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 5.6] [Reference Citation Analysis]
214 Seyfrid M, Marschall V, Fulda S. Reactive oxygen species contribute toward Smac mimetic/temozolomide-induced cell death in glioblastoma cells. Anticancer Drugs 2016;27:953-9. [PMID: 27669171 DOI: 10.1097/CAD.0000000000000412] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
215 Sharma P, Srinivasa Reddy T, Thummuri D, Senwar KR, Praveen Kumar N, Naidu V, Bhargava SK, Shankaraiah N. Synthesis and biological evaluation of new benzimidazole-thiazolidinedione hybrids as potential cytotoxic and apoptosis inducing agents. European Journal of Medicinal Chemistry 2016;124:608-21. [DOI: 10.1016/j.ejmech.2016.08.029] [Cited by in Crossref: 70] [Cited by in F6Publishing: 73] [Article Influence: 10.0] [Reference Citation Analysis]
216 Sumi H, Inazuka M, Morimoto M, Hibino R, Hashimoto K, Ishikawa T, Kuida K, Smith PG, Yoshida S, Yabuki M. An inhibitor of apoptosis protein antagonist T-3256336 potentiates the antitumor efficacy of the Nedd8-activating enzyme inhibitor pevonedistat (TAK-924/MLN4924). Biochem Biophys Res Commun 2016;480:380-6. [PMID: 27771247 DOI: 10.1016/j.bbrc.2016.10.058] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
217 Sharma P, Thummuri D, Reddy TS, Senwar KR, Naidu V, Srinivasulu G, Bharghava SK, Shankaraiah N. New ( E )-1-alkyl-1 H -benzo[ d ]imidazol-2-yl)methylene)indolin-2-ones: Synthesis, in vitro cytotoxicity evaluation and apoptosis inducing studies. European Journal of Medicinal Chemistry 2016;122:584-600. [DOI: 10.1016/j.ejmech.2016.07.019] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 6.0] [Reference Citation Analysis]
218 Wang S, Xu Y, Chan HF, Kim H, Wang Y, Leong KW, Chen M. Nanoparticle-mediated inhibition of survivin to overcome drug resistance in cancer therapy. Journal of Controlled Release 2016;240:454-64. [DOI: 10.1016/j.jconrel.2016.04.018] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 5.4] [Reference Citation Analysis]
219 Nguyen J, Chen L, Kumar D, Lee J. Facile synthesis of autophagonizer and evaluation of its activity to induce autophagic cell death in apoptosis-defective cell line. Bioorganic & Medicinal Chemistry Letters 2016;26:4753-6. [DOI: 10.1016/j.bmcl.2016.08.035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
220 Czaplinski S, Abhari BA, Torkov A, Seggewiß D, Hugle M, Fulda S. Differential role of RIP1 in Smac mimetic-mediated chemosensitization of neuroblastoma cells. Oncotarget 2015;6:41522-34. [PMID: 26575016 DOI: 10.18632/oncotarget.6308] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
221 Subba Rao AV, Vishnu Vardhan MV, Subba Reddy NV, Srinivasa Reddy T, Shaik SP, Bagul C, Kamal A. Synthesis and biological evaluation of imidazopyridinyl-1,3,4-oxadiazole conjugates as apoptosis inducers and topoisomerase IIα inhibitors. Bioorg Chem 2016;69:7-19. [PMID: 27656775 DOI: 10.1016/j.bioorg.2016.09.002] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
222 Hu T, Li Z, Gao CY, Cho CH. Mechanisms of drug resistance in colon cancer and its therapeutic strategies. World J Gastroenterol 2016; 22(30): 6876-6889 [PMID: 27570424 DOI: 10.3748/wjg.v22.i30.6876] [Cited by in CrossRef: 205] [Cited by in F6Publishing: 214] [Article Influence: 29.3] [Reference Citation Analysis]
223 Meister MT, Boedicker C, Graab U, Hugle M, Hahn H, Klingebiel T, Fulda S. Arsenic trioxide induces Noxa-dependent apoptosis in rhabdomyosarcoma cells and synergizes with antimicrotubule drugs. Cancer Lett 2016;381:287-95. [PMID: 27521572 DOI: 10.1016/j.canlet.2016.07.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
224 Li X, Heimann K, Dinh XT, Keene FR, Collins JG. Biological processing of dinuclear ruthenium complexes in eukaryotic cells. Mol Biosyst 2016;12:3032-45. [PMID: 27453040 DOI: 10.1039/c6mb00431h] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
225 Sindhu J, Singh H, Khurana JM, Bhardwaj JK, Saraf P, Sharma C. Synthesis and biological evaluation of some functionalized 1H-1,2,3-triazole tethered pyrazolo[3,4-b]pyridin-6(7H)-ones as antimicrobial and apoptosis inducing agents. Med Chem Res 2016;25:1813-30. [DOI: 10.1007/s00044-016-1604-0] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
226 Garufi A, Trisciuoglio D, Cirone M, D'Orazi G. ZnCl2 sustains the adriamycin-induced cell death inhibited by high glucose. Cell Death Dis 2016;7:e2280. [PMID: 27362798 DOI: 10.1038/cddis.2016.178] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
227 Burns KE, McCleerey TP, Thévenin D. pH-Selective Cytotoxicity of pHLIP-Antimicrobial Peptide Conjugates. Sci Rep 2016;6:28465. [PMID: 27334357 DOI: 10.1038/srep28465] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 6.3] [Reference Citation Analysis]
228 Fulda S. Redox regulation of Smac mimetic-induced cell death. Mol Cell Oncol 2015;2:e1000697. [PMID: 27308489 DOI: 10.1080/23723556.2014.1000697] [Reference Citation Analysis]
229 Lu SF, Huang Y, Wang N, Shen WX, Fu SP, Li Q, Yu ML, Liu WX, Chen X, Jing XY, Zhu BM. Cardioprotective Effect of Electroacupuncture Pretreatment on Myocardial Ischemia/Reperfusion Injury via Antiapoptotic Signaling. Evid Based Complement Alternat Med 2016;2016:4609784. [PMID: 27313648 DOI: 10.1155/2016/4609784] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
230 Reiter M, Eckhardt I, Haferkamp A, Fulda S. Smac mimetic sensitizes renal cell carcinoma cells to interferon-α-induced apoptosis. Cancer Letters 2016;375:1-8. [DOI: 10.1016/j.canlet.2016.02.019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
231 Gerges S, Rohde K, Fulda S. Cotreatment with Smac mimetics and demethylating agents induces both apoptotic and necroptotic cell death pathways in acute lymphoblastic leukemia cells. Cancer Letters 2016;375:127-32. [DOI: 10.1016/j.canlet.2016.02.040] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
232 Liu K, Jiang T, Ouyang Y, Shi Y, Zang Y, Li N, Lu S, Chen D. Nuclear EGFR impairs ASPP2-p53 complex-induced apoptosis by inducing SOS1 expression in hepatocellular carcinoma. Oncotarget 2015;6:16507-16. [PMID: 25980493 DOI: 10.18632/oncotarget.3757] [Cited by in Crossref: 17] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
233 Lindemann C, Marschall V, Weigert A, Klingebiel T, Fulda S. Smac Mimetic-Induced Upregulation of CCL2/MCP-1 Triggers Migration and Invasion of Glioblastoma Cells and Influences the Tumor Microenvironment in a Paracrine Manner. Neoplasia 2015;17:481-9. [PMID: 26152356 DOI: 10.1016/j.neo.2015.05.002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
234 Choene M, Motadi L. Validation of the antiproliferative effects of Euphorbia tirucalli extracts in breast cancer cell lines. Mol Biol 2016;50:98-110. [DOI: 10.1134/s0026893316010040] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
235 Cortese FA, Santostasi G. Whole-Body Induced Cell Turnover: A Proposed Intervention for Age-Related Damage and Associated Pathology. Rejuvenation Res 2016;19:322-36. [PMID: 26649945 DOI: 10.1089/rej.2015.1763] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
236 Tan G, Wu L, Tan J, Zhang B, Tai WC, Xiong S, Chen W, Yang J, Li H. MiR-1180 promotes apoptotic resistance to human hepatocellular carcinoma via activation of NF-κB signaling pathway. Sci Rep 2016;6:22328. [PMID: 26928365 DOI: 10.1038/srep22328] [Cited by in Crossref: 35] [Cited by in F6Publishing: 40] [Article Influence: 5.0] [Reference Citation Analysis]
237 Chow MJ, Licona C, Pastorin G, Mellitzer G, Ang WH, Gaiddon C. Structural tuning of organoruthenium compounds allows oxidative switch to control ER stress pathways and bypass multidrug resistance. Chem Sci 2016;7:4117-24. [PMID: 30155055 DOI: 10.1039/c6sc00268d] [Cited by in Crossref: 58] [Cited by in F6Publishing: 58] [Article Influence: 8.3] [Reference Citation Analysis]
238 Salem A, Noaman E, Kandil E, Badawi A, Mostafa N. Crystal structure and chemotherapeutic efficacy of the novel compound, gallium tetrachloride betaine, against breast cancer using nanotechnology. Tumour Biol 2016;37:11025-38. [PMID: 26894603 DOI: 10.1007/s13277-016-4969-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
239 Graab U, Hahn H, Fulda S. Identification of a novel synthetic lethality of combined inhibition of hedgehog and PI3K signaling in rhabdomyosarcoma. Oncotarget 2015;6:8722-35. [PMID: 25749378 DOI: 10.18632/oncotarget.2726] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 5.6] [Reference Citation Analysis]
240 Chandra V, Kim JJ, Mittal B, Rai R. MicroRNA aberrations: An emerging field for gallbladder cancer management. World J Gastroenterol 2016; 22(5): 1787-1799 [PMID: 26855538 DOI: 10.3748/wjg.v22.i5.1787] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
241 Wang F, Qiang Y, Zhu L, Jiang Y, Wang Y, Shao X, Yin L, Chen J, Chen Z. MicroRNA-7 downregulates the oncogene VDAC1 to influence hepatocellular carcinoma proliferation and metastasis. Tumour Biol 2016;37:10235-46. [PMID: 26831666 DOI: 10.1007/s13277-016-4836-1] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 4.1] [Reference Citation Analysis]
242 Evans MK, Sauer SJ, Nath S, Robinson TJ, Morse MA, Devi GR. X-linked inhibitor of apoptosis protein mediates tumor cell resistance to antibody-dependent cellular cytotoxicity. Cell Death Dis 2016;7:e2073. [PMID: 26821068 DOI: 10.1038/cddis.2015.412] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 4.4] [Reference Citation Analysis]
243 Schirmer M, Trentin L, Queudeville M, Seyfried F, Demir S, Tausch E, Stilgenbauer S, Eckhoff SM, Meyer LH, Debatin KM. Intrinsic and chemo-sensitizing activity of SMAC-mimetics on high-risk childhood acute lymphoblastic leukemia. Cell Death Dis 2016;7:e2052. [PMID: 26775704 DOI: 10.1038/cddis.2015.382] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
244 Haß C, Belz K, Schoeneberger H, Fulda S. Sensitization of acute lymphoblastic leukemia cells for LCL161-induced cell death by targeting redox homeostasis. Biochem Pharmacol 2016;105:14-22. [PMID: 26774450 DOI: 10.1016/j.bcp.2016.01.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
245 Praveen Kumar C, Reddy TS, Mainkar PS, Bansal V, Shukla R, Chandrasekhar S, Hügel HM. Synthesis and biological evaluation of 5,10-dihydro-11 H -dibenzo[ b,e ][1,4]diazepin-11-one structural derivatives as anti-cancer and apoptosis inducing agents. European Journal of Medicinal Chemistry 2016;108:674-86. [DOI: 10.1016/j.ejmech.2015.12.007] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 5.6] [Reference Citation Analysis]
246 Roos J, Grösch S, Werz O, Schröder P, Ziegler S, Fulda S, Paulus P, Urbschat A, Kühn B, Maucher I, Fettel J, Vorup-jensen T, Piesche M, Matrone C, Steinhilber D, Parnham MJ, Maier TJ. Regulation of tumorigenic Wnt signaling by cyclooxygenase-2, 5-lipoxygenase and their pharmacological inhibitors: A basis for novel drugs targeting cancer cells? Pharmacology & Therapeutics 2016;157:43-64. [DOI: 10.1016/j.pharmthera.2015.11.001] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
247 Moreira AJ, Ordoñez R, Cerski CT, Picada JN, García-Palomo A, Marroni NP, Mauriz JL, González-Gallego J. Melatonin Activates Endoplasmic Reticulum Stress and Apoptosis in Rats with Diethylnitrosamine-Induced Hepatocarcinogenesis. PLoS One 2015;10:e0144517. [PMID: 26656265 DOI: 10.1371/journal.pone.0144517] [Cited by in Crossref: 52] [Cited by in F6Publishing: 56] [Article Influence: 6.5] [Reference Citation Analysis]
248 Nalivaiko K, Hofmann M, Kober K, Teichweyde N, Krammer PH, Rammensee HG, Grosse-Hovest L, Jung G. A Recombinant Bispecific CD20×CD95 Antibody With Superior Activity Against Normal and Malignant B-cells. Mol Ther 2016;24:298-305. [PMID: 26581163 DOI: 10.1038/mt.2015.209] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
249 Xu J, Xu X, Shi S, Wang Q, Saxton B, He W, Gou X, Jang JH, Nyunoya T, Wang X, Xing C, Zhang L, Lin Y. Autophagy-Mediated Degradation of IAPs and c-FLIP(L) Potentiates Apoptosis Induced by Combination of TRAIL and Chal-24. J Cell Biochem 2016;117:1136-44. [PMID: 26448608 DOI: 10.1002/jcb.25397] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
250 Hwang HS, Kim HA. Chondrocyte Apoptosis in the Pathogenesis of Osteoarthritis. Int J Mol Sci 2015;16:26035-54. [PMID: 26528972 DOI: 10.3390/ijms161125943] [Cited by in Crossref: 393] [Cited by in F6Publishing: 411] [Article Influence: 49.1] [Reference Citation Analysis]
251 Wang TW, Vermeulen RC, Hu W, Liu G, Xiao X, Alekseyev Y, Xu J, Reiss B, Steiling K, Downward GS, Silverman DT, Wei F, Wu G, Li J, Lenburg ME, Rothman N, Spira A, Lan Q. Gene-expression profiling of buccal epithelium among non-smoking women exposed to household air pollution from smoky coal. Carcinogenesis 2015;36:1494-501. [PMID: 26468118 DOI: 10.1093/carcin/bgv150] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
252 Marschall V, Fulda S. Smac mimetic-induced upregulation of interferon-β sensitizes glioblastoma to temozolomide-induced cell death. Cell Death Dis 2015;6:e1888. [PMID: 26379193 DOI: 10.1038/cddis.2015.235] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
253 Weiß LM, Hugle M, Romero S, Fulda S. Synergistic induction of apoptosis by a polo-like kinase 1 inhibitor and microtubule-interfering drugs in Ewing sarcoma cells: Synergistic combinations with PLK1 inhibitors in Ewing sarcoma. Int J Cancer 2016;138:497-506. [DOI: 10.1002/ijc.29725] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
254 Hernández-Corbacho MJ, Canals D, Adada MM, Liu M, Senkal CE, Yi JK, Mao C, Luberto C, Hannun YA, Obeid LM. Tumor Necrosis Factor-α (TNFα)-induced Ceramide Generation via Ceramide Synthases Regulates Loss of Focal Adhesion Kinase (FAK) and Programmed Cell Death. J Biol Chem 2015;290:25356-73. [PMID: 26318452 DOI: 10.1074/jbc.M115.658658] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 4.8] [Reference Citation Analysis]
255 Naci D, Vuori K, Aoudjit F. Alpha2beta1 integrin in cancer development and chemoresistance. Semin Cancer Biol 2015;35:145-53. [PMID: 26297892 DOI: 10.1016/j.semcancer.2015.08.004] [Cited by in Crossref: 72] [Cited by in F6Publishing: 77] [Article Influence: 9.0] [Reference Citation Analysis]
256 Reddy TS, Kulhari H, Reddy VG, Bansal V, Kamal A, Shukla R. Design, synthesis and biological evaluation of 1,3-diphenyl-1 H -pyrazole derivatives containing benzimidazole skeleton as potential anticancer and apoptosis inducing agents. European Journal of Medicinal Chemistry 2015;101:790-805. [DOI: 10.1016/j.ejmech.2015.07.031] [Cited by in Crossref: 133] [Cited by in F6Publishing: 108] [Article Influence: 16.6] [Reference Citation Analysis]
257 Zhao Q, Huo XC, Sun FD, Dong RQ. Polyphenol-rich extract of Salvia chinensis exhibits anticancer activity in different cancer cell lines, and induces cell cycle arrest at the G₀/G₁-phase, apoptosis and loss of mitochondrial membrane potential in pancreatic cancer cells. Mol Med Rep 2015;12:4843-50. [PMID: 26165362 DOI: 10.3892/mmr.2015.4074] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
258 Sheibani S, Jones NK, Eid R, Gharib N, Arab NTT, Titorenko V, Vali H, Young PA, Greenwood MT, Mazzoni C. Inhibition of stress mediated cell death by human lactate dehydrogenase B in yeast. FEMS Yeast Research 2015;15:fov032. [DOI: 10.1093/femsyr/fov032] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
259 Liese J, Abhari BA, Fulda S. Smac mimetic and oleanolic acid synergize to induce cell death in human hepatocellular carcinoma cells. Cancer Lett 2015;365:47-56. [PMID: 25917078 DOI: 10.1016/j.canlet.2015.04.018] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
260 Stehle A, Hugle M, Fulda S. Eribulin synergizes with Polo-like kinase 1 inhibitors to induce apoptosis in rhabdomyosarcoma. Cancer Lett. 2015;365:37-46. [PMID: 25917079 DOI: 10.1016/j.canlet.2015.04.011] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
261 Zorofchian Moghadamtousi S, Rouhollahi E, Karimian H, Fadaeinasab M, Firoozinia M, Ameen Abdulla M, Abdul Kadir H. The chemopotential effect of Annona muricata leaves against azoxymethane-induced colonic aberrant crypt foci in rats and the apoptotic effect of Acetogenin Annomuricin E in HT-29 cells: a bioassay-guided approach. PLoS One 2015;10:e0122288. [PMID: 25860620 DOI: 10.1371/journal.pone.0122288] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 5.5] [Reference Citation Analysis]
262 Papadopoulos EI, Yousef GM, Scorilas A. Gemcitabine impacts differentially on bladder and kidney cancer cells: distinct modulations in the expression patterns of apoptosis-related microRNAs and BCL2 family genes. Tumour Biol 2015;36:3197-207. [PMID: 25833690 DOI: 10.1007/s13277-014-2190-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
263 Fulda S. Targeting apoptosis for anticancer therapy. Seminars in Cancer Biology 2015;31:84-8. [DOI: 10.1016/j.semcancer.2014.05.002] [Cited by in Crossref: 122] [Cited by in F6Publishing: 133] [Article Influence: 15.3] [Reference Citation Analysis]
264 Hu T, Wang L, Zhang L, Lu L, Shen J, Chan RL, Li M, Wu WK, To KK, Cho CH. Sensitivity of apoptosis-resistant colon cancer cells to tanshinones is mediated by autophagic cell death and p53-independent cytotoxicity. Phytomedicine. 2015;22:536-544. [PMID: 25981919 DOI: 10.1016/j.phymed.2015.03.010] [Cited by in Crossref: 58] [Cited by in F6Publishing: 65] [Article Influence: 7.3] [Reference Citation Analysis]
265 Fang WB, Yao M, Jokar I, Alhakamy N, Berkland C, Chen J, Brantley-Sieders D, Cheng N. The CCL2 chemokine is a negative regulator of autophagy and necrosis in luminal B breast cancer cells. Breast Cancer Res Treat 2015;150:309-20. [PMID: 25744294 DOI: 10.1007/s10549-015-3324-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
266 Wang N, Feng Y. Elaborating the role of natural products-induced autophagy in cancer treatment: achievements and artifacts in the state of the art. Biomed Res Int 2015;2015:934207. [PMID: 25821829 DOI: 10.1155/2015/934207] [Cited by in Crossref: 20] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
267 Jenkins MR, Rudd-Schmidt JA, Lopez JA, Ramsbottom KM, Mannering SI, Andrews DM, Voskoboinik I, Trapani JA. Failed CTL/NK cell killing and cytokine hypersecretion are directly linked through prolonged synapse time. J Exp Med 2015;212:307-17. [PMID: 25732304 DOI: 10.1084/jem.20140964] [Cited by in Crossref: 143] [Cited by in F6Publishing: 146] [Article Influence: 17.9] [Reference Citation Analysis]
268 Shi S, Wang Q, Xu J, Jang JH, Padilla MT, Nyunoya T, Xing C, Zhang L, Lin Y. Synergistic anticancer effect of cisplatin and Chal-24 combination through IAP and c-FLIPL degradation, Ripoptosome formation and autophagy-mediated apoptosis. Oncotarget 2015;6:1640-51. [PMID: 25682199 DOI: 10.18632/oncotarget.2746] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
269 Hugle M, Fulda S. Dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 synergizes with chloroquine to induce apoptosis in embryonal rhabdomyosarcoma. Cancer Lett 2015;360:1-9. [PMID: 25637161 DOI: 10.1016/j.canlet.2014.12.016] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
270 Rogers L, Senge MO. The translocator protein as a potential molecular target for improved treatment efficacy in photodynamic therapy. Future Med Chem 2014;6:775-92. [PMID: 24941872 DOI: 10.4155/fmc.14.37] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
271 Fulda S. Targeting extrinsic apoptosis in cancer: Challenges and opportunities. Semin Cell Dev Biol. 2015;39:20-25. [PMID: 25617598 DOI: 10.1016/j.semcdb.2015.01.006] [Cited by in Crossref: 67] [Cited by in F6Publishing: 71] [Article Influence: 8.4] [Reference Citation Analysis]
272 Billard C. Apoptosis inducers in chronic lymphocytic leukemia. Oncotarget. 2014;5:309-325. [PMID: 24525395 DOI: 10.18632/oncotarget.1480] [Cited by in Crossref: 41] [Cited by in F6Publishing: 45] [Article Influence: 5.1] [Reference Citation Analysis]
273 Silveira GG, Oliveira-costa JP, Ribeiro-silva A. Breast Cancer Stem Cells. Cancer Stem Cells: Emerging Concepts and Future Perspectives in Translational Oncology 2015. [DOI: 10.1007/978-3-319-21030-8_7] [Reference Citation Analysis]
274 Srinivasa Reddy T, Kulhari H, Ganga Reddy V, Subba Rao AV, Bansal V, Kamal A, Shukla R. Synthesis and biological evaluation of pyrazolo–triazole hybrids as cytotoxic and apoptosis inducing agents. Org Biomol Chem 2015;13:10136-49. [DOI: 10.1039/c5ob00842e] [Cited by in Crossref: 60] [Cited by in F6Publishing: 62] [Article Influence: 7.5] [Reference Citation Analysis]
275 Ždralević M, Longo V, Guaragnella N, Giannattasio S, Timperio AM, Zolla L. Differential proteome–metabolome profiling of YCA1-knock-out and wild type cells reveals novel metabolic pathways and cellular processes dependent on the yeast metacaspase. Mol BioSyst 2015;11:1573-83. [DOI: 10.1039/c4mb00660g] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
276 Klingebiel T, Bader P, Fulda S. Grundlagen der pädiatrischen Onkologie. Pädiatrie 2015. [DOI: 10.1007/978-3-642-54671-6_224-1] [Reference Citation Analysis]
277 Wang W, Xie Q, Zhou X, Yao J, Zhu X, Huang P, Zhang L, Wei J, Xie H, Zhou L. Mitofusin-2 triggers mitochondria Ca2+ influx from the endoplasmic reticulum to induce apoptosis in hepatocellular carcinoma cells. Cancer Lett. 2015;358:47-58. [PMID: 25541060 DOI: 10.1016/j.canlet.2014.12.025] [Cited by in Crossref: 82] [Cited by in F6Publishing: 88] [Article Influence: 9.1] [Reference Citation Analysis]
278 Schoeneberger H, Belz K, Schenk B, Fulda S. Impairment of antioxidant defense via glutathione depletion sensitizes acute lymphoblastic leukemia cells for Smac mimetic-induced cell death. Oncogene 2015;34:4032-43. [PMID: 25381820 DOI: 10.1038/onc.2014.338] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
279 Rahmani-nezhad S, Safavi M, Pordeli M, Ardestani SK, Khosravani L, Pourshojaei Y, Mahdavi M, Emami S, Foroumadi A, Shafiee A. Synthesis, in vitro cytotoxicity and apoptosis inducing study of 2-aryl-3-nitro-2H-chromene derivatives as potent anti-breast cancer agents. European Journal of Medicinal Chemistry 2014;86:562-9. [DOI: 10.1016/j.ejmech.2014.09.017] [Cited by in Crossref: 74] [Cited by in F6Publishing: 77] [Article Influence: 8.2] [Reference Citation Analysis]
280 Beesoo R, Neergheen-bhujun V, Bhagooli R, Bahorun T. Apoptosis inducing lead compounds isolated from marine organisms of potential relevance in cancer treatment. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2014;768:84-97. [DOI: 10.1016/j.mrfmmm.2014.03.005] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 5.4] [Reference Citation Analysis]
281 Xiang Q, Ma Y, Dong J, Shen R. Carnosic acid induces apoptosis associated with mitochondrial dysfunction and Akt inactivation in HepG2 cells. Int J Food Sci Nutr. 2015;66:76-84. [PMID: 25265205 DOI: 10.3109/09637486.2014.953452] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
282 Luo TY, Cheng PC, Chiang PF, Chuang TW, Yeh CH, Lin WJ. 188Re-HYNIC-trastuzumab enhances the effect of apoptosis induced by trastuzumab in HER2-overexpressing breast cancer cells. Ann Nucl Med 2015;29:52-62. [PMID: 25238789 DOI: 10.1007/s12149-014-0908-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
283 Bake V, Roesler S, Eckhardt I, Belz K, Fulda S. Synergistic interaction of Smac mimetic and IFNα to trigger apoptosis in acute myeloid leukemia cells. Cancer Lett 2014;355:224-31. [PMID: 25179908 DOI: 10.1016/j.canlet.2014.08.040] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 3.2] [Reference Citation Analysis]
284 Wang WH, Tyan YC, Chen ZS, Lin CG, Yang MH, Yuan SS, Tsai WC. Evaluation of the antioxidant activity and antiproliferative effect of the jaboticaba (Myrciaria cauliflora) seed extracts in oral carcinoma cells. Biomed Res Int 2014;2014:185946. [PMID: 25197631 DOI: 10.1155/2014/185946] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
285 Gao X, Jin W. The emerging role of tumor-suppressive microRNA-218 in targeting glioblastoma stemness. Cancer Lett 2014;353:25-31. [PMID: 25042866 DOI: 10.1016/j.canlet.2014.07.011] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 4.6] [Reference Citation Analysis]
286 Mthembu NN, Motadi LR. Apoptotic potential role of Agave palmeri and Tulbaghia violacea extracts in cervical cancer cells. Mol Biol Rep 2014;41:6143-55. [DOI: 10.1007/s11033-014-3493-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
287 Li X, Zeng X, Sun J, Li H, Wu P, Fung K, Liu F. Imperatorin induces Mcl-1 degradation to cooperatively trigger Bax translocation and Bak activation to suppress drug-resistant human hepatoma. Cancer Letters 2014;348:146-155. [DOI: 10.1016/j.canlet.2014.03.017] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
288 Meng B, Wang Y, Li B. Suppression of PAX6 promotes cell proliferation and inhibits apoptosis in human retinoblastoma cells. Int J Mol Med 2014;34:399-408. [PMID: 24939714 DOI: 10.3892/ijmm.2014.1812] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
289 Hassan M, Watari H, AbuAlmaaty A, Ohba Y, Sakuragi N. Apoptosis and molecular targeting therapy in cancer. Biomed Res Int. 2014;2014:150845. [PMID: 25013758 DOI: 10.1155/2014/150845] [Cited by in Crossref: 555] [Cited by in F6Publishing: 687] [Article Influence: 61.7] [Reference Citation Analysis]
290 Liu CY, Su JC, Ni MH, Tseng LM, Chu PY, Wang DS, Tai WT, Kao YP, Hung MH, Shiau CW, Chen KF. Obatoclax analog SC-2001 inhibits STAT3 phosphorylation through enhancing SHP-1 expression and induces apoptosis in human breast cancer cells. Breast Cancer Res Treat 2014;146:71-84. [PMID: 24903225 DOI: 10.1007/s10549-014-3000-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
291 Vlahovic G, Karantza V, Wang D, Cosgrove D, Rudersdorf N, Yang J, Xiong H, Busman T, Mabry M. A phase I safety and pharmacokinetic study of ABT-263 in combination with carboplatin/paclitaxel in the treatment of patients with solid tumors. Invest New Drugs 2014;32:976-84. [PMID: 24894650 DOI: 10.1007/s10637-014-0116-3] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 4.1] [Reference Citation Analysis]
292 Hirschi B, Gallmeier E, Ziesch A, Marschall M, Kolligs FT. Genetic targeting of B-RafV600E affects survival and proliferation and identifies selective agents against BRAF-mutant colorectal cancer cells. Mol Cancer 2014;13:122. [PMID: 24885690 DOI: 10.1186/1476-4598-13-122] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
293 Belz K, Schoeneberger H, Wehner S, Weigert A, Bönig H, Klingebiel T, Fichtner I, Fulda S. Smac mimetic and glucocorticoids synergize to induce apoptosis in childhood ALL by promoting ripoptosome assembly. Blood 2014;124:240-50. [PMID: 24855207 DOI: 10.1182/blood-2013-05-500918] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 4.0] [Reference Citation Analysis]
294 de Renty C, DePamphilis ML, Ullah Z. Cytoplasmic localization of p21 protects trophoblast giant cells from DNA damage induced apoptosis. PLoS One 2014;9:e97434. [PMID: 24848107 DOI: 10.1371/journal.pone.0097434] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
295 Zhang X, Zhang S, Zhu S, Chen S, Han J, Gao K, Zeng J, Yan X. Identification of Mitochondria-Targeting Anticancer Compounds by an in Vitro Strategy. Anal Chem 2014;86:5232-7. [DOI: 10.1021/ac500918g] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
296 Fulda S. Synthetic lethality by co-targeting mitochondrial apoptosis and PI3K/Akt/mTOR signaling. Mitochondrion 2014;19 Pt A:85-7. [PMID: 24780492 DOI: 10.1016/j.mito.2014.04.011] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 3.1] [Reference Citation Analysis]
297 Friesen C, Hormann I, Roscher M, Fichtner I, Alt A, Hilger R, Debatin KM, Miltner E. Opioid receptor activation triggering downregulation of cAMP improves effectiveness of anti-cancer drugs in treatment of glioblastoma. Cell Cycle 2014;13:1560-70. [PMID: 24626197 DOI: 10.4161/cc.28493] [Cited by in Crossref: 62] [Cited by in F6Publishing: 65] [Article Influence: 6.9] [Reference Citation Analysis]
298 Gunda V, Bucur O, Varnau J, Vanden Borre P, Bernasconi MJ, Khosravi-Far R, Parangi S. Blocks to thyroid cancer cell apoptosis can be overcome by inhibition of the MAPK and PI3K/AKT pathways. Cell Death Dis. 2014;5:e1104. [PMID: 24603332 DOI: 10.1038/cddis.2014.78] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 4.0] [Reference Citation Analysis]
299 Rai R, Sharma KL, Sharma S, Misra S, Kumar A, Mittal B. Death receptor (DR4) haplotypes are associated with increased susceptibility of gallbladder carcinoma in north Indian population. PLoS One 2014;9:e90264. [PMID: 24587306 DOI: 10.1371/journal.pone.0090264] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
300 Friesen C, Roscher M, Hormann I, Fichtner I, Alt A, Hilger RA, Debatin KM, Miltner E. Cell death sensitization of leukemia cells by opioid receptor activation. Oncotarget 2013;4:677-90. [PMID: 23633472 DOI: 10.18632/oncotarget.952] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 5.9] [Reference Citation Analysis]
301 Fulda S. Inhibitor of Apoptosis (IAP) proteins in hematological malignancies: molecular mechanisms and therapeutic opportunities. Leukemia 2014;28:1414-22. [PMID: 24487414 DOI: 10.1038/leu.2014.56] [Cited by in Crossref: 42] [Cited by in F6Publishing: 46] [Article Influence: 4.7] [Reference Citation Analysis]
302 Roscher M, Hormann I, Leib O, Marx S, Moreno J, Miltner E, Friesen C. Targeted alpha-therapy using [Bi-213]anti-CD20 as novel treatment option for radio- and chemoresistant non-Hodgkin lymphoma cells. Oncotarget 2013;4:218-30. [PMID: 23474846 DOI: 10.18632/oncotarget.817] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
303 Fulda S. Inhibitor of apoptosis proteins in pediatric leukemia: molecular pathways and novel approaches to therapy. Front Oncol 2014;4:3. [PMID: 24478984 DOI: 10.3389/fonc.2014.00003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
304 Pfister C, Pfrommer H, Tatagiba MS, Roser F. Detection and quantification of farnesol-induced apoptosis in difficult primary cell cultures by TaqMan protein assay. Apoptosis 2013;18:452-66. [PMID: 23315006 DOI: 10.1007/s10495-012-0796-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
305 Fulda S. Tumor-necrosis-factor-related apoptosis-inducing ligand (TRAIL). Adv Exp Med Biol 2014;818:167-80. [PMID: 25001536 DOI: 10.1007/978-1-4471-6458-6_8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
306 Klingebiel T, Bader P, Fulda S. Grundlagen der Onkologie. Pädiatrie 2014. [DOI: 10.1007/978-3-642-41866-2_182] [Reference Citation Analysis]
307 Tokar T, Ulicny J. The mathematical model of the Bcl-2 family mediated MOMP regulation can perform a non-trivial pattern recognition. PLoS One 2013;8:e81861. [PMID: 24386084 DOI: 10.1371/journal.pone.0081861] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
308 Roy SS, Chakraborty P, Bhattacharya S. Intervention in cyclophosphamide induced oxidative stress and DNA damage by a flavonyl-thiazolidinedione based organoselenocyanate and evaluation of its efficacy during adjuvant therapy in tumor bearing mice. Eur J Med Chem 2014;73:195-209. [PMID: 24412495 DOI: 10.1016/j.ejmech.2013.12.015] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
309 Krizanova O, Steliarova I, Csaderova L, Pastorek M, Hudecova S. Capsaicin induces apoptosis in PC12 cells through ER stress. Oncol Rep 2014;31:581-8. [PMID: 24337105 DOI: 10.3892/or.2013.2921] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
310 Eid R, Sheibani S, Gharib N, Lapointe JF, Horowitz A, Vali H, Mandato CA, Greenwood MT. Human ribosomal protein L9 is a Bax suppressor that promotes cell survival in yeast. FEMS Yeast Res 2014;14:495-507. [DOI: 10.1111/1567-1364.12121] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
311 Yu L, Liu S. Autophagy contributes to modulating the cytotoxicities of Bcl-2 homology domain-3 mimetics. Semin Cancer Biol 2013;23:553-60. [PMID: 24012660 DOI: 10.1016/j.semcancer.2013.08.008] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
312 Eckhardt I, Roesler S, Fulda S. Identification of DR5 as a critical, NF-κB-regulated mediator of Smac-induced apoptosis. Cell Death Dis 2013;4:e936. [PMID: 24287697 DOI: 10.1038/cddis.2013.457] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 3.7] [Reference Citation Analysis]
313 Salminen A, Kauppinen A, Hiltunen M, Kaarniranta K. Epigenetic regulation of ASC/TMS1 expression: potential role in apoptosis and inflammasome function. Cell Mol Life Sci 2014;71:1855-64. [PMID: 24287895 DOI: 10.1007/s00018-013-1524-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
314 Elsum IA, Yates LL, Pearson HB, Phesse TJ, Long F, O'donoghue R, Ernst M, Cullinane C, Humbert PO. Scrib heterozygosity predisposes to lung cancer and cooperates with KRas hyperactivation to accelerate lung cancer progression in vivo. Oncogene 2014;33:5523-33. [DOI: 10.1038/onc.2013.498] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 3.9] [Reference Citation Analysis]
315 Zhong J, Yang L, Liu N, Zheng J, Lin CY. Knockdown of inhibitor of growth protein 2 inhibits cell invasion and enhances chemosensitivity to 5-FU in human gastric cancer cells. Dig Dis Sci 2013;58:3189-97. [PMID: 23864195 DOI: 10.1007/s10620-013-2796-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
316 Preuss E, Hugle M, Reimann R, Schlecht M, Fulda S. Pan-mammalian target of rapamycin (mTOR) inhibitor AZD8055 primes rhabdomyosarcoma cells for ABT-737-induced apoptosis by down-regulating Mcl-1 protein. J Biol Chem 2013;288:35287-96. [PMID: 24133218 DOI: 10.1074/jbc.M113.495986] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 5.2] [Reference Citation Analysis]
317 Katsetos CD, Anni H, Dráber P. Mitochondrial dysfunction in gliomas. Semin Pediatr Neurol 2013;20:216-27. [PMID: 24331363 DOI: 10.1016/j.spen.2013.09.003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
318 Anderegg MCJ, Corsten MF. MicroRNA Adjuvants in Stem Cell-Based Cancer Therapy. Stem Cell Therapeutics for Cancer 2013. [DOI: 10.1002/9781118660423.ch15] [Reference Citation Analysis]
319 Pinto CA, Widodo E, Waltham M, Thompson EW. Breast cancer stem cells and epithelial mesenchymal plasticity - Implications for chemoresistance. Cancer Lett. 2013;341:56-62. [PMID: 23830804 DOI: 10.1016/j.canlet.2013.06.003] [Cited by in Crossref: 75] [Cited by in F6Publishing: 79] [Article Influence: 7.5] [Reference Citation Analysis]
320 Zhang X, Wei H, Liu Z, Yuan Q, Wei A, Shi D, Yang X, Ruan J. A novel protoapigenone analog RY10-4 induces breast cancer MCF-7 cell death through autophagy via the Akt/mTOR pathway. Toxicology and Applied Pharmacology 2013;270:122-8. [DOI: 10.1016/j.taap.2013.04.011] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
321 Tokar T, Turcan Z, Ulicny J. Boolean network-based model of the Bcl-2 family mediated MOMP regulation. Theor Biol Med Model 2013;10:40. [PMID: 23767791 DOI: 10.1186/1742-4682-10-40] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
322 Friesen C, Roscher M, Hormann I, Leib O, Marx S, Moreno J, Miltner E. Anti-CD33-antibodies labelled with the alpha-emitter Bismuth-213 kill CD33-positive acute myeloid leukaemia cells specifically by activation of caspases and break radio- and chemoresistance by inhibition of the anti-apoptotic proteins X-linked inhibitor of apoptosis protein and B-cell lymphoma-extra large. Eur J Cancer 2013;49:2542-54. [PMID: 23684782 DOI: 10.1016/j.ejca.2013.04.008] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
323 Yang N, Goping IS. Apoptosis. Colloquium Series on Building Blocks of the Cell: Cell Structure and Function 2013;1:1-101. [DOI: 10.4199/c00080ed1v01y201303bbc003] [Reference Citation Analysis]
324 Iida K, Fukushi J, Matsumoto Y, Oda Y, Takahashi Y, Fujiwara T, Fujiwara-Okada Y, Hatano M, Nabashima A, Kamura S, Iwamoto Y. miR-125b develops chemoresistance in Ewing sarcoma/primitive neuroectodermal tumor. Cancer Cell Int 2013;13:21. [PMID: 23497288 DOI: 10.1186/1475-2867-13-21] [Cited by in Crossref: 45] [Cited by in F6Publishing: 52] [Article Influence: 4.5] [Reference Citation Analysis]
325 Fulda S. Regulation of cell death in cancer-possible implications for immunotherapy. Front Oncol. 2013;3:29. [PMID: 23441073 DOI: 10.3389/fonc.2013.00029] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
326 Fulda S. Harnessing Death Receptor Signaling for Cancer Treatment. Cell Death Signaling in Cancer Biology and Treatment 2013. [DOI: 10.1007/978-1-4614-5847-0_11] [Reference Citation Analysis]
327 Fulda S. Strategies to Overcome TRAIL Resistance in Cancer. Resistance to Targeted Anti-Cancer Therapeutics 2013. [DOI: 10.1007/978-1-4614-7654-2_8] [Reference Citation Analysis]
328 Fulda S. Targeting c-FLICE-like inhibitory protein (CFLAR) in cancer. Expert Opin Ther Targets 2013;17:195-201. [PMID: 23252466 DOI: 10.1517/14728222.2013.736499] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 2.7] [Reference Citation Analysis]
329 Adnan H, Quach H, MacIntosh K, Antenos M, Kirby GM. Low levels of GSTA1 expression are required for Caco-2 cell proliferation. PLoS One 2012;7:e51739. [PMID: 23251616 DOI: 10.1371/journal.pone.0051739] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
330 Cristofanon S, Fulda S. ABT-737 promotes tBid mitochondrial accumulation to enhance TRAIL-induced apoptosis in glioblastoma cells. Cell Death Dis 2012;3:e432. [PMID: 23190604 DOI: 10.1038/cddis.2012.163] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 3.5] [Reference Citation Analysis]
331 Biggers JW, Nguyen T, Di X, Gupton JT, Henderson SC, Emery SM, Alotaibi M, White KL, Brown R, Almenara J. Autophagy, cell death and sustained senescence arrest in B16/F10 melanoma cells and HCT-116 colon carcinoma cells in response to the novel microtubule poison, JG-03-14. Cancer Chemother Pharmacol. 2013;71:441-455. [PMID: 23178952 DOI: 10.1007/s00280-012-2024-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
332 Jang JH, Iqbal T, Min KJ, Kim S, Park JW, Son EI, Lee TJ, Kwon TK. Helenalin-induced apoptosis is dependent on production of reactive oxygen species and independent of induction of endoplasmic reticulum stress in renal cell carcinoma. Toxicol In Vitro 2013;27:588-96. [PMID: 23123298 DOI: 10.1016/j.tiv.2012.10.014] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
333 Fulda S. Shifting the balance of mitochondrial apoptosis: therapeutic perspectives. Front Oncol 2012;2:121. [PMID: 23061040 DOI: 10.3389/fonc.2012.00121] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
334 Antony H, Wiegmans AP, Wei MQ, Chernoff YO, Khanna KK, Munn AL. Potential roles for prions and protein-only inheritance in cancer. Cancer Metastasis Rev 2012;31:1-19. [PMID: 22138778 DOI: 10.1007/s10555-011-9325-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
335 Bush BM, Brock AT, Deng JA, Nelson RA, Sumter TF. The Wnt/β-catenin/T-cell factor 4 pathway up-regulates high-mobility group A1 expression in colon cancer. Cell Biochem Funct. 2013;31:228-236. [PMID: 22961697 DOI: 10.1002/cbf.2876] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 2.7] [Reference Citation Analysis]
336 Shimizu Y, Mullins N, Blanchard Z, Elshamy WM. BRCA1/p220 loss triggers BRCA1-IRIS overexpression via mRNA stabilization in breast cancer cells. Oncotarget 2012;3:299-313. [PMID: 22431556 DOI: 10.18632/oncotarget.462] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
337 Basit F, Humphreys R, Fulda S. RIP1 protein-dependent assembly of a cytosolic cell death complex is required for inhibitor of apoptosis (IAP) inhibitor-mediated sensitization to lexatumumab-induced apoptosis. J Biol Chem 2012;287:38767-77. [PMID: 22927431 DOI: 10.1074/jbc.M112.398966] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
338 Abhari BA, Cristofanon S, Kappler R, von Schweinitz D, Humphreys R, Fulda S. RIP1 is required for IAP inhibitor-mediated sensitization for TRAIL-induced apoptosis via a RIP1/FADD/caspase-8 cell death complex. Oncogene 2013;32:3263-73. [PMID: 22890322 DOI: 10.1038/onc.2012.337] [Cited by in Crossref: 48] [Cited by in F6Publishing: 52] [Article Influence: 4.4] [Reference Citation Analysis]
339 Gold E, Risbridger G. Activins and activin antagonists in the prostate and prostate cancer. Molecular and Cellular Endocrinology 2012;359:107-12. [DOI: 10.1016/j.mce.2011.07.005] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
340 Gatsinzi T, Ivanova EV, Iverfeldt K. TRAIL resistance in human neuroblastoma SK-N-AS cells is dependent on protein kinase C and involves inhibition of caspase-3 proteolytic processing. J Neurooncol 2012;109:503-12. [PMID: 22798207 DOI: 10.1007/s11060-012-0932-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
341 Kemeny S, Dery D, Loboda Y, Rovner M, Lev T, Zuri D, Finberg JP, Larisch S. Parkin promotes degradation of the mitochondrial pro-apoptotic ARTS protein. PLoS One 2012;7:e38837. [PMID: 22792159 DOI: 10.1371/journal.pone.0038837] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
342 Fulda S. Histone deacetylase (HDAC) inhibitors and regulation of TRAIL-induced apoptosis. Experimental Cell Research 2012;318:1208-12. [DOI: 10.1016/j.yexcr.2012.02.005] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
343 Lopez PL, Filippi-chiela EC, Silva AO, Cordero EA, Garcia-santos D, Pelegrini AL, Reder GM, Barbieri NL, Lenz G. Sensitization of Glioma Cells by X-Linked Inhibitor of Apoptosis Protein Knockdown. Oncology 2012;83:75-82. [DOI: 10.1159/000337978] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
344 Clapp C, Portt L, Khoury C, Sheibani S, Eid R, Greenwood M, Vali H, Mandato CA, Greenwood MT. Untangling the Roles of Anti-Apoptosis in Regulating Programmed Cell Death using Humanized Yeast Cells. Front Oncol 2012;2:59. [PMID: 22708116 DOI: 10.3389/fonc.2012.00059] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
345 Vitovski S, Chantry AD, Lawson MA, Croucher PI. Targeting tumour-initiating cells with TRAIL based combination therapy ensures complete and lasting eradication of multiple myeloma tumours in vivo. PLoS One 2012;7:e35830. [PMID: 22615740 DOI: 10.1371/journal.pone.0035830] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
346 Shimizu Y, Luk H, Horio D, Miron P, Griswold M, Iglehart D, Hernandez B, Killeen J, ElShamy WM. BRCA1-IRIS overexpression promotes formation of aggressive breast cancers. PLoS One 2012;7:e34102. [PMID: 22511931 DOI: 10.1371/journal.pone.0034102] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
347 Aoudjit F, Vuori K. Integrin signaling in cancer cell survival and chemoresistance. Chemother Res Pract 2012;2012:283181. [PMID: 22567280 DOI: 10.1155/2012/283181] [Cited by in Crossref: 58] [Cited by in F6Publishing: 107] [Article Influence: 5.3] [Reference Citation Analysis]
348 Wagner L, Marschall V, Karl S, Cristofanon S, Zobel K, Deshayes K, Vucic D, Debatin KM, Fulda S. Smac mimetic sensitizes glioblastoma cells to Temozolomide-induced apoptosis in a RIP1- and NF-κB-dependent manner. Oncogene 2013;32:988-97. [PMID: 22469979 DOI: 10.1038/onc.2012.108] [Cited by in Crossref: 74] [Cited by in F6Publishing: 75] [Article Influence: 6.7] [Reference Citation Analysis]
349 Laukens B, Jennewein C, Schenk B, Vanlangenakker N, Schier A, Cristofanon S, Zobel K, Deshayes K, Vucic D, Jeremias I, Bertrand MJ, Vandenabeele P, Fulda S. Smac mimetic bypasses apoptosis resistance in FADD- or caspase-8-deficient cells by priming for tumor necrosis factor α-induced necroptosis. Neoplasia 2011;13:971-9. [PMID: 22028622 DOI: 10.1593/neo.11610] [Cited by in Crossref: 78] [Cited by in F6Publishing: 82] [Article Influence: 7.1] [Reference Citation Analysis]
350 Fulda S. Inhibitor of Apoptosis (IAP) proteins as therapeutic targets for radiosensitization of human cancers. Cancer Treat Rev 2012;38:760-6. [PMID: 22342104 DOI: 10.1016/j.ctrv.2012.01.005] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
351 Lee P, Zhang R, Li V, Liu X, Sun RW, Che CM, Wong KK. Enhancement of anticancer efficacy using modified lipophilic nanoparticle drug encapsulation. Int J Nanomedicine 2012;7:731-7. [PMID: 22359452 DOI: 10.2147/IJN.S28783] [Cited by in Crossref: 7] [Cited by in F6Publishing: 15] [Article Influence: 0.6] [Reference Citation Analysis]
352 Zdralević M, Guaragnella N, Antonacci L, Marra E, Giannattasio S. Yeast as a tool to study signaling pathways in mitochondrial stress response and cytoprotection. ScientificWorldJournal 2012;2012:912147. [PMID: 22454613 DOI: 10.1100/2012/912147] [Cited by in Crossref: 26] [Cited by in F6Publishing: 32] [Article Influence: 2.4] [Reference Citation Analysis]
353 Fulda S, Vucic D. Targeting IAP proteins for therapeutic intervention in cancer. Nat Rev Drug Discov. 2012;11:109-124. [PMID: 22293567 DOI: 10.1038/nrd3627] [Cited by in Crossref: 593] [Cited by in F6Publishing: 617] [Article Influence: 53.9] [Reference Citation Analysis]
354 Fulda S. Cell death pathways as therapeutic targets in rhabdomyosarcoma. Sarcoma 2012;2012:326210. [PMID: 22294874 DOI: 10.1155/2012/326210] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
355 Du J, Tang B, Wang J, Sui H, Jin X, Wang L, Wang Z. Antiproliferative effect of alpinetin in BxPC-3 pancreatic cancer cells. Int J Mol Med 2012;29:607-12. [PMID: 22246103 DOI: 10.3892/ijmm.2012.884] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
356 Fulda S. Exploiting inhibitor of apoptosis proteins as therapeutic targets in hematological malignancies. Leukemia 2012;26:1155-65. [PMID: 22230799 DOI: 10.1038/leu.2012.4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
357 Bortner CD, Scoltock AB, Sifre MI, Cidlowski JA. Osmotic stress resistance imparts acquired anti-apoptotic mechanisms in lymphocytes. J Biol Chem 2012;287:6284-95. [PMID: 22228768 DOI: 10.1074/jbc.M111.293001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
358 Colombatti A, Spessotto P, Doliana R, Mongiat M, Bressan GM, Esposito G. The EMILIN/Multimerin family. Front Immunol 2011;2:93. [PMID: 22566882 DOI: 10.3389/fimmu.2011.00093] [Cited by in Crossref: 32] [Cited by in F6Publishing: 52] [Article Influence: 2.9] [Reference Citation Analysis]
359 Reischer-pelech D, Flescher E. Jasmonates: Plant Stress Hormones as Anticancer Agents. ACS Symposium Series 2012. [DOI: 10.1021/bk-2012-1093.ch017] [Reference Citation Analysis]
360 Das S, Chatterjee M. Apoptotic Regulators and Its Clinical Implications in Mammary Carcinoma. Novel Apoptotic Regulators in Carcinogenesis 2012. [DOI: 10.1007/978-94-007-4917-7_9] [Reference Citation Analysis]
361 Löder S, Fakler M, Schoeneberger H, Cristofanon S, Leibacher J, Vanlangenakker N, Bertrand MJ, Vandenabeele P, Jeremias I, Debatin KM, Fulda S. RIP1 is required for IAP inhibitor-mediated sensitization of childhood acute leukemia cells to chemotherapy-induced apoptosis. Leukemia 2012;26:1020-9. [PMID: 22173242 DOI: 10.1038/leu.2011.353] [Cited by in Crossref: 51] [Cited by in F6Publishing: 57] [Article Influence: 4.3] [Reference Citation Analysis]
362 Fulda S, Kroemer G. Mitochondria as therapeutic targets for the treatment of malignant disease. Antioxid Redox Signal 2011;15:2937-49. [PMID: 21644835 DOI: 10.1089/ars.2011.4078] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 4.7] [Reference Citation Analysis]
363 Wen Y, Gorsic LK, Wheeler HE, Ziliak DM, Huang RS, Dolan ME. Chemotherapeutic-induced apoptosis: a phenotype for pharmacogenomics studies. Pharmacogenet Genomics 2011;21:476-88. [PMID: 21642893 DOI: 10.1097/FPC.0b013e3283481967] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
364 Fulda S. Molekular zielgerichtete Krebstherapien bei Tumoren im Kindesalter. Onkologe 2011;17:1045-1051. [DOI: 10.1007/s00761-011-2152-3] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
365 Sedlmaier A, Wernert N, Gallitzendörfer R, Abouzied MM, Gieselmann V, Franken S. Overexpression of hepatoma-derived growth factor in melanocytes does not lead to oncogenic transformation. BMC Cancer 2011;11:457. [PMID: 22014102 DOI: 10.1186/1471-2407-11-457] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
366 Fulda S. Novel insights into the synergistic interaction of Bortezomib and TRAIL: tBid provides the link. Oncotarget 2011;2:418-21. [PMID: 21789791 DOI: 10.18632/oncotarget.277] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
367 Fulda S. Targeting apoptosis signaling pathways for anticancer therapy. Front Oncol 2011;1:23. [PMID: 22655234 DOI: 10.3389/fonc.2011.00023] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
368 Scabini M, Stellari F, Cappella P, Rizzitano S, Texido G, Pesenti E. In vivo imaging of early stage apoptosis by measuring real-time caspase-3/7 activation. Apoptosis 2011;16:198-207. [PMID: 21082356 DOI: 10.1007/s10495-010-0553-1] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 4.3] [Reference Citation Analysis]
369 Cree IA. Cancer biology. Methods Mol Biol 2011;731:1-11. [PMID: 21516393 DOI: 10.1007/978-1-61779-080-5_1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
370 Iyer AK, Azad N, Talbot S, Stehlik C, Lu B, Wang L, Rojanasakul Y. Antioxidant c-FLIP inhibits Fas ligand-induced NF-kappaB activation in a phosphatidylinositol 3-kinase/Akt-dependent manner. J Immunol 2011;187:3256-66. [PMID: 21856935 DOI: 10.4049/jimmunol.1002915] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
371 Bangert A, Häcker S, Cristofanon S, Debatin K, Fulda S. Chemosensitization of glioblastoma cells by the histone deacetylase inhibitor MS275. Anti-Cancer Drugs 2011;22:494-9. [DOI: 10.1097/cad.0b013e32834631e0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
372 Hoffmann R, von Schwarzenberg K, López-Antón N, Rudy A, Wanner G, Dirsch VM, Vollmar AM. Helenalin bypasses Bcl-2-mediated cell death resistance by inhibiting NF-κB and promoting reactive oxygen species generation. Biochem Pharmacol 2011;82:453-63. [PMID: 21669190 DOI: 10.1016/j.bcp.2011.05.029] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
373 Schipper JL, MacKenzie SH, Sharma A, Clark AC. A bifunctional allosteric site in the dimer interface of procaspase-3. Biophys Chem 2011;159:100-9. [PMID: 21645959 DOI: 10.1016/j.bpc.2011.05.013] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
374 Li Z, Xu X, Bai L, Chen W, Lin Y. Epidermal growth factor receptor-mediated tissue transglutaminase overexpression couples acquired tumor necrosis factor-related apoptosis-inducing ligand resistance and migration through c-FLIP and MMP-9 proteins in lung cancer cells. J Biol Chem 2011;286:21164-72. [PMID: 21525012 DOI: 10.1074/jbc.M110.207571] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 4.7] [Reference Citation Analysis]
375 Plati J, Bucur O, Khosravi-Far R. Apoptotic cell signaling in cancer progression and therapy. Integr Biol (Camb). 2011;3:279-296. [PMID: 21340093 DOI: 10.1039/c0ib00144a] [Cited by in Crossref: 178] [Cited by in F6Publishing: 190] [Article Influence: 14.8] [Reference Citation Analysis]
376 Gatsinzi T, Iverfeldt K. Sensitization to TRAIL-induced apoptosis in human neuroblastoma SK-N-AS cells by NF-κB inhibitors is dependent on reactive oxygen species (ROS). J Neurooncol 2011;104:459-72. [DOI: 10.1007/s11060-010-0516-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
377 Fulda S. Targeting apoptosis signaling in pancreatic cancer. Cancers (Basel). 2011;3:241-251. [PMID: 24212616 DOI: 10.3390/cancers3010241] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
378 Zhang LQ, Heruth DP, Ye SQ. Nicotinamide Phosphoribosyltransferase in Human Diseases. J Bioanal Biomed 2011;3:13-25. [PMID: 22140607 DOI: 10.4172/1948-593X.1000038] [Cited by in Crossref: 79] [Cited by in F6Publishing: 90] [Article Influence: 6.6] [Reference Citation Analysis]
379 Gassar ES, Ibrahim SA, Götte M. Heparan Sulfate Proteoglycans in Cancer Therapy. Glycans in Diseases and Therapeutics 2011. [DOI: 10.1007/978-3-642-16833-8_6] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
380 Williams D, Norman G, Khoury C, Metcalfe N, Briard J, Laporte A, Sheibani S, Portt L, Mandato CA, Greenwood MT. Evidence for a second messenger function of dUTP during Bax mediated apoptosis of yeast and mammalian cells. Biochim Biophys Acta 2011;1813:315-21. [PMID: 21145358 DOI: 10.1016/j.bbamcr.2010.11.021] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
381 Salminen A, Ojala J, Kaarniranta K. Apoptosis and aging: increased resistance to apoptosis enhances the aging process. Cell Mol Life Sci. 2011;68:1021-1031. [PMID: 21116678 DOI: 10.1007/s00018-010-0597-y] [Cited by in Crossref: 89] [Cited by in F6Publishing: 79] [Article Influence: 6.8] [Reference Citation Analysis]
382 Arlt A, Müerköster SS, Schäfer H. Targeting apoptosis pathways in pancreatic cancer. Cancer Lett. 2013;332:346-358. [PMID: 21078544 DOI: 10.1016/j.canlet.2010.10.015] [Cited by in Crossref: 90] [Cited by in F6Publishing: 99] [Article Influence: 6.9] [Reference Citation Analysis]
383 Fulda S. Exploiting mitochondrial apoptosis for the treatment of cancer. Mitochondrion 2010;10:598-603. [DOI: 10.1016/j.mito.2010.05.001] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 2.2] [Reference Citation Analysis]
384 Fulda S. Targeting apoptosis pathways in childhood malignancies. Cancer Lett 2013;332:369-73. [PMID: 21036468 DOI: 10.1016/j.canlet.2010.10.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
385 Portt L, Norman G, Clapp C, Greenwood M, Greenwood MT. Anti-apoptosis and cell survival: a review. Biochim Biophys Acta. 2011;1813:238-259. [PMID: 20969895 DOI: 10.1016/j.bbamcr.2010.10.010] [Cited by in Crossref: 415] [Cited by in F6Publishing: 386] [Article Influence: 31.9] [Reference Citation Analysis]
386 Leja-Szpak A, Jaworek J, Pierzchalski P, Reiter RJ. Melatonin induces pro-apoptotic signaling pathway in human pancreatic carcinoma cells (PANC-1). J Pineal Res 2010;49:248-55. [PMID: 20626591 DOI: 10.1111/j.1600-079X.2010.00789.x] [Cited by in Crossref: 96] [Cited by in F6Publishing: 96] [Article Influence: 7.4] [Reference Citation Analysis]
387 Brozmanová J, Mániková D, Vlčková V, Chovanec M. Selenium: a double-edged sword for defense and offence in cancer. Arch Toxicol 2010;84:919-38. [PMID: 20871980 DOI: 10.1007/s00204-010-0595-8] [Cited by in Crossref: 232] [Cited by in F6Publishing: 211] [Article Influence: 17.8] [Reference Citation Analysis]
388 Azmi AS, Wang Z, Philip PA, Mohammad RM, Sarkar FH. Emerging Bcl-2 inhibitors for the treatment of cancer. Expert Opin Emerg Drugs. 2011;16:59-70. [PMID: 20812891 DOI: 10.1517/14728214.2010.515210] [Cited by in Crossref: 80] [Cited by in F6Publishing: 83] [Article Influence: 6.2] [Reference Citation Analysis]
389 Mongiat M, Marastoni S, Ligresti G, Lorenzon E, Schiappacassi M, Perris R, Frustaci S, Colombatti A. The extracellular matrix glycoprotein elastin microfibril interface located protein 2: a dual role in the tumor microenvironment. Neoplasia 2010;12:294-304. [PMID: 20360940 DOI: 10.1593/neo.91930] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 3.2] [Reference Citation Analysis]
390 Randhawa SR, Chahine BG, Lowery-Nordberg M, Cotelingam JD, Casillas AM. Underexpression and overexpression of Fas and Fas ligand: a double-edged sword. Ann Allergy Asthma Immunol 2010;104:286-92. [PMID: 20408337 DOI: 10.1016/j.anai.2010.01.021] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
391 Fulda S, Galluzzi L, Kroemer G. Targeting mitochondria for cancer therapy. Nat Rev Drug Discov. 2010;9:447-464. [PMID: 20467424 DOI: 10.1038/nrd3137] [Cited by in Crossref: 1164] [Cited by in F6Publishing: 1209] [Article Influence: 89.5] [Reference Citation Analysis]
392 Cao W, Yang X, Zhou J, Teng Z, Cao L, Zhang X, Fei Z. Targeting 14-3-3 protein, difopein induces apoptosis of human glioma cells and suppresses tumor growth in mice. Apoptosis. 2010;15:230-241. [PMID: 20033782 DOI: 10.1007/s10495-009-0437-4] [Cited by in Crossref: 50] [Cited by in F6Publishing: 54] [Article Influence: 3.8] [Reference Citation Analysis]
393 Ordys BB, Launay S, Deighton RF, Mcculloch J, Whittle IR. The Role of Mitochondria in Glioma Pathophysiology. Mol Neurobiol 2010;42:64-75. [DOI: 10.1007/s12035-010-8133-5] [Cited by in Crossref: 60] [Cited by in F6Publishing: 56] [Article Influence: 4.6] [Reference Citation Analysis]
394 Loeder S, Drensek A, Jeremias I, Debatin KM, Fulda S. Small molecule XIAP inhibitors sensitize childhood acute leukemia cells for CD95-induced apoptosis. Int J Cancer 2010;126:2216-28. [PMID: 19676052 DOI: 10.1002/ijc.24816] [Cited by in Crossref: 6] [Cited by in F6Publishing: 17] [Article Influence: 0.5] [Reference Citation Analysis]
395 Beljanski V, Knaak C, Smith CD. A novel sphingosine kinase inhibitor induces autophagy in tumor cells. J Pharmacol Exp Ther 2010;333:454-64. [PMID: 20179157 DOI: 10.1124/jpet.109.163337] [Cited by in Crossref: 83] [Cited by in F6Publishing: 90] [Article Influence: 6.4] [Reference Citation Analysis]
396 Fulda S. Evasion of apoptosis as a cellular stress response in cancer. Int J Cell Biol. 2010;2010:370835. [PMID: 20182539 DOI: 10.1155/2010/370835] [Cited by in Crossref: 71] [Cited by in F6Publishing: 93] [Article Influence: 5.5] [Reference Citation Analysis]
397 Sawyer MB, Field CJ. Possible Mechanisms of ω-3 PUFA Anti-tumour Action. Dietary Omega-3 Polyunsaturated Fatty Acids and Cancer 2010. [DOI: 10.1007/978-90-481-3579-0_1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
398 Hardman WE. The Influence of ω-3 PUFAs on Chemo- or Radiation Therapy for Cancer. Dietary Omega-3 Polyunsaturated Fatty Acids and Cancer 2010. [DOI: 10.1007/978-90-481-3579-0_9] [Reference Citation Analysis]
399 Metodieva S, Cherneva R, Nikolova D, Genchev G, Petrov D, Toncheva D. Apoptosis Gene Expression Profile in Early-Stage non Small Cell Lung Cancer. Balkan Journal of Medical Genetics 2010;13:47-52. [DOI: 10.2478/v10034-010-0026-4] [Reference Citation Analysis]
400 Robert F, Pelletier J. Translation initiation: a critical signalling node in cancer. Expert Opin Ther Targets 2009;13:1279-93. [PMID: 19705976 DOI: 10.1517/14728220903241625] [Cited by in Crossref: 38] [Cited by in F6Publishing: 43] [Article Influence: 2.7] [Reference Citation Analysis]
401 Chen W, Bai L, Wang X, Xu S, Belinsky SA, Lin Y. Acquired activation of the Akt/cyclooxygenase-2/Mcl-1 pathway renders lung cancer cells resistant to apoptosis. Mol Pharmacol 2010;77:416-23. [PMID: 19933775 DOI: 10.1124/mol.109.061226] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 3.0] [Reference Citation Analysis]
402 Yeh C, Rao YK, Yao C, Yeh C, Li C, Chuang S, Luong JH, Lai G, Tzeng Y. Cytotoxic triterpenes from Antrodia camphorata and their mode of action in HT-29 human colon cancer cells. Cancer Letters 2009;285:73-9. [DOI: 10.1016/j.canlet.2009.05.002] [Cited by in Crossref: 93] [Cited by in F6Publishing: 96] [Article Influence: 6.6] [Reference Citation Analysis]
403 Vellanki SH, Grabrucker A, Liebau S, Proepper C, Eramo A, Braun V, Boeckers T, Debatin KM, Fulda S. Small-molecule XIAP inhibitors enhance gamma-irradiation-induced apoptosis in glioblastoma. Neoplasia 2009;11:743-52. [PMID: 19649204 DOI: 10.1593/neo.09436] [Cited by in Crossref: 86] [Cited by in F6Publishing: 92] [Article Influence: 6.1] [Reference Citation Analysis]
404 Sallese M, Giannotta M, Luini A. Coordination of the secretory compartments via inter-organelle signalling. Seminars in Cell & Developmental Biology 2009;20:801-9. [DOI: 10.1016/j.semcdb.2009.04.004] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
405 Su M, Wu X, Chung HY, Li Y, Ye W. Antiproliferative Activities of Five Chinese Medicinal Herbs and Active Compounds in Elephantopus scaber. Natural Product Communications 2009;4:1934578X0900400. [DOI: 10.1177/1934578x0900400802] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
406 Deng Y, Balunas MJ, Kim JA, Lantvit DD, Chin YW, Chai H, Sugiarso S, Kardono LB, Fong HH, Pezzuto JM, Swanson SM, de Blanco EJ, Kinghorn AD. Bioactive 5,6-dihydro-alpha-pyrone derivatives from Hyptis brevipes. J Nat Prod 2009;72:1165-9. [PMID: 19422206 DOI: 10.1021/np9001724] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 3.0] [Reference Citation Analysis]